This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_BREAST_EXALLC for full statistics.
Malignant neoplasm of breast
C3_BREAST
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
24134 |
4. Check minimum number of eventsNone |
24134 |
5. Include endpointsNone |
24134 |
6. Filter based on genotype QC (FinnGen only) |
24134 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of breast
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 24134 | 24134 | - |
| Unadjusted period prevalence (%) | 8.23 | 8.23 | - |
| Median age at first event (years) | 59.58 | 59.58 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 21238
- Matched controls
- 156492
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C50.52
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor
805.8
323.0
429
*
8500/3-C50.1
ICD-O-3
Infiltrating duct carcinoma, NOS, of central portion of breast
+∞
323.0
497
*
HWD00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of mammary gland
30.0
323.0
599
151
1744A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-outer quadrant
1771.8
323.0
720
*
TQB05
NOMESCO Finland
Puncture of skin of trunk
31.6
323.0
706
170
C50.10
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, no histological veryfication
224.5
323.0
445
15
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.8
323.0
12539
43151
A03FA01
ATC
metoclopramide; systemic, rectal
6.6
323.0
10422
19980
A04AA55
ATC
palonosetron, combinations; systemic
35.9
323.0
3368
817
C50.20
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication
636.8
323.0
589
7
A04AD12
ATC
aprepitant; systemic
29.5
323.0
1877
512
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
+∞
323.0
1107
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
322.4
323.0
6693
223
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
455.8
323.0
719
12
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
516.2
323.0
2204
35
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
14.2
323.0
681
364
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
194.2
323.0
2775
121
ZX090
NOMESCO Finland
Other technic of radiotherapy
23.1
323.0
1890
659
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
285.2
323.0
2045
58
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
550.9
323.0
9933
251
I97.2
ICD-10 Finland
Postmastectomy lymphoedema syndrome
318.0
323.0
549
13
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
31.2
323.0
8153
3061
TQW20
NOMESCO Finland
Tatoe
196.3
323.0
1441
58
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
68.4
323.0
525
58
HAE05
NOMESCO Finland
Reconstruction of breast using soft tissue and prosthesis
247.5
323.0
624
19
8500/3-C50.3
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast
+∞
323.0
471
*
XX2AT
NOMESCO Finland
Other injection with ultrasound examination
33.0
323.0
1187
280
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
411.6
323.0
2121
42
HA3AT
NOMESCO Finland
Pucture of mammary gland cyst with ultrasound examination
31.9
323.0
594
141
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
7.2
323.0
3843
4666
HAD99
NOMESCO Finland
Other plastic operation on breast
32.4
323.0
503
117
L02BG03
ATC
anastrozole; oral
1171.1
323.0
2131
15
M05BX04
ATC
denosumab; parenteral
3.5
323.0
1802
4057
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
317.5
323.0
2180
56
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
63.9
323.0
450
53
C50.99
ICD-10 Finland
Breast, unspecified
281.0
323.0
3984
129
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
43.7
323.0
5135
1134
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
43.2
323.0
1172
211
WX402
NOMESCO Finland
General anaesthesia
2.7
323.0
4506
14193
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
1111.5
323.0
1132
8
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.7
323.0
10401
32136
L01BC06
ATC
capecitabine; oral
6.2
323.0
1360
1704
C50.22
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor
382.4
323.0
607
12
HAE99
NOMESCO Finland
Other reconstruction of breast
67.4
323.0
844
96
A04AA02
ATC
granisetron; systemic, transdermal
16.8
323.0
4557
2510
8520/3-C50.4
ICD-O-3
Lobular carcinoma, NOS, of upper-outer quadrant of breast
+∞
323.0
759
*
115
Kela drug reimbursment
Breast cancer
+∞
323.0
15678
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
323.0
1597
*
8500/3-C50.8
ICD-O-3
Infiltrating duct carcinoma, NOS, of overlapping lesion of breast
+∞
323.0
403
*
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
378.1
323.0
1351
28
N63
ICD-10 Finland
Unspecified lump in breast
5.5
323.0
3329
5072
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
196.2
323.0
670
26
D70.82
ICD-10 Finland
Drug-induced neutropenia
11.0
323.0
817
569
C50.12
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,lobular tumor
289.8
323.0
464
12
HAC25
NOMESCO Finland
Radical mastectomy
1718.2
323.0
471
*
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
15.6
323.0
726
354
C50.9
ICD-10 Finland
Malignant neoplasm: Breast, unspecified
416.0
323.0
605
11
H02AB02
ATC
dexamethasone; systemic
18.6
323.0
8336
5262
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
489.5
323.0
893
14
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
1657.2
323.0
893
*
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
17.5
323.0
1364
612
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
29.1
323.0
3731
1139
Z31.5
ICD-10 Finland
Genetic counselling
6.6
323.0
2358
2907
WF003
NOMESCO Finland
Adjuvant radiotherapy
16.0
323.0
2363
1213
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
449.6
323.0
5883
132
HAC15
NOMESCO Finland
Subcutaneous mastectomy with excision of mamilla
195.4
323.0
865
34
HAE00
NOMESCO Finland
Reconstruction of breast using prosthesis
117.6
323.0
499
32
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
136.7
323.0
2777
172
ZZF00
NOMESCO Finland
Graft of adipose tissue
28.7
323.0
720
191
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
32.4
323.0
5344
1608
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
472.3
323.0
744
12
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
1091.2
323.0
3678
30
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
34.0
323.0
2406
586
WX702
NOMESCO Finland
Supraglottic ventilation device
3.9
323.0
1755
3501
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
74.8
323.0
4137
505
R4110
NOMESCO Finland
Physiotherapy
2.5
323.0
7187
26614
HA1AA
NOMESCO Finland
X-ray mammography
33.1
323.0
9454
3701
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
323.0
8284
*
L02BA01
ATC
tamoxifen; oral
523.6
323.0
6409
128
A04AA01
ATC
ondansetron; systemic, rectal
4.3
323.0
2547
4839
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
741.9
323.0
2802
32
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
268.7
323.0
2692
85
L02BG04
ATC
letrozole; oral
158.4
323.0
8955
718
9707
FHL
Ablation of mammae and removal of axillary lymph nodes
752.1
323.0
692
7
C50
ICD-10 Finland
Malignant neoplasm of breast
603.7
323.0
3268
47
C50.92
ICD-10 Finland
Malignant tumor in another specified localization in lobular gland, lobular tumor
175.5
323.0
466
20
C50.80
ICD-10 Finland
Overall malignant tumor of the mammary gland, no histological veryfication
759.8
323.0
405
*
L02BG06
ATC
exemestane; oral
7454.1
323.0
1864
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
274.0
323.0
3043
96
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
216.4
323.0
1849
69
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
16.8
323.0
1228
570
ZX112
NOMESCO Finland
Subcutaneous
9.3
323.0
910
753
WZC30
NOMESCO Finland
Teaching
3.5
323.0
4050
9947
HAB40
NOMESCO Finland
Wedge excision of mammary gland
151.3
323.0
8031
627
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
60.1
323.0
1888
254
XX1XN
NOMESCO Finland
Other isotope examination
301.3
323.0
1018
26
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
39.7
323.0
506
96
JN4BD
NOMESCO Finland
Extensive body CT
4.0
323.0
3461
7264
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
323.0
3201
*
ZZR10
NOMESCO Finland
Flap of skin and muscle
53.0
323.0
756
109
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
5.3
323.0
1224
1795
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
13.0
323.0
670
390
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
299.8
323.0
2004
54
PJW99
NOMESCO Finland
Other operation on lymphatic system
193.8
323.0
513
20
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
97.5
323.0
1152
92
1501
Kela drug reimbursment
Palbociclib
+∞
323.0
576
*
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
33.8
323.0
846
192
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
323.0
1943
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
382.3
323.0
2197
47
L03AA02
ATC
filgrastim; parenteral
6.6
323.0
1049
1218
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
241.3
323.0
1846
62
PJA12
NOMESCO Finland
Sentinel node biopsy
189.3
323.0
12412
1154
X76
ICPC
Malignant neoplasm breast female
437.8
323.0
2616
50
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
96.4
323.0
2887
255
QB2S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in chest
59.4
323.0
557
71
394
Kela drug reimbursment
Palbociclib
+∞
323.0
515
*
HAB00
NOMESCO Finland
Excision of lesion of mammary gland
5.0
323.0
1278
1971
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
61.7
323.0
3205
449
1CD02
NOMESCO Finland
NA
266.6
323.0
873
25
HA1TE
NOMESCO Finland
Supplementary or limited ultrasound examination of mammary glands
16.6
323.0
854
393
NK6AN
NOMESCO Finland
Total body bone isotope imaging
64.8
323.0
1891
236
HA1BG
NOMESCO Finland
MRI examination of mammary gland with high intensity magnet
59.4
323.0
724
93
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
434.3
323.0
1738
32
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
130.0
323.0
4444
318
HAB99
NOMESCO Finland
Other partial excision of mammary gland
28.6
323.0
2631
771
HAD30
NOMESCO Finland
Reduction mammoplasty with transposition of areola
6.8
323.0
2235
2647
ZXA05
NOMESCO Finland
Left side
2.0
323.0
6287
26964
WX404
NOMESCO Finland
Intravenous generell anesthesy
4.0
323.0
7849
20141
L03AA14
ATC
lipegfilgrastim; parenteral
21.7
323.0
1577
575
ZXA00
NOMESCO Finland
Right side
1.9
323.0
6546
29325
L01XE33
ATC
[U] palbociclib; oral
+∞
323.0
407
*
HA6BA
NOMESCO Finland
Breast tomosynthesis specimen
105.1
323.0
1275
95
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
12.0
323.0
777
495
ZSH00
NOMESCO Finland
Procedure related to previous procedure classified in chapter H
146.1
323.0
560
29
8500/3-C50.5
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast
+∞
323.0
702
*
FM1FN
NOMESCO Finland
Heart function isotope examination
89.2
323.0
543
46
ZX120
NOMESCO Finland
Intravenous
3.6
323.0
2923
6709
L03AA13
ATC
pegfilgrastim; parenteral
26.6
323.0
3664
1215
Z51.0
ICD-10 Finland
Radiotherapy session
21.7
323.0
673
236
XX3DW
NOMESCO Finland
Time consuming IT work
9.0
323.0
5348
5668
L02BA03
ATC
fulvestrant; parenteral
1074.0
323.0
562
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.7
323.0
1920
3241
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
6.2
323.0
1078
1333
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
101.4
323.0
405
30
ZX080
NOMESCO Finland
Image guided radiotherapy
41.3
323.0
1834
357
192
Kela drug reimbursment
Fulvestrant
+∞
323.0
531
*
HAC20
NOMESCO Finland
Total mastectomy
569.7
323.0
6755
127
C50.59
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology
342.8
323.0
457
10
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
59.8
323.0
1894
256
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
323.0
9049
40660
C50.19
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, other or undeterminated histology
230.6
323.0
516
17
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
536.5
323.0
1925
29
1XC03
NOMESCO Finland
NA
339.8
321.5
364
8
HA1HA
NOMESCO Finland
Tomosynthesis mammography
29.4
320.5
480
123
Z42.1
ICD-10 Finland
Follow-up care involving plastic surgery of breast
21.7
319.3
519
180
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
4.7
317.7
1231
2041
C50.39
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology
855.6
310.8
343
*
HAD40
NOMESCO Finland
Mastopexy
28.9
299.3
450
117
C50.50
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication
1259.4
298.0
327
*
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
98.0
297.6
366
28
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
13.3
291.4
566
322
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
27.1
288.0
440
122
D48.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Breast
5.7
286.0
917
1222
L01EF01
ATC
palbociclib; oral
+∞
283.2
306
*
N02BE01
ATC
paracetamol; systemic, rectal
2.1
282.1
18830
123188
X21
ICPC
Breast sympt/compl female other
5.8
280.9
886
1156
HA4ST
NOMESCO Finland
Labeling mammary gland pathology with sterotactic guidance
53.0
280.9
374
53
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.7
279.2
1388
2901
WF049
NOMESCO Finland
Radiotherapy of metastasis
5.5
270.6
897
1244
HWA00
NOMESCO Finland
Repair of wound dehiscence in surgery of mammary gland
45.7
268.2
366
60
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
266.9
5784
26469
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
265.0
8748
45663
HA1SA
NOMESCO Finland
Expansion mammography
37.0
263.8
375
76
C50.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of breast
1098.9
263.8
290
*
C50.2
ICD-10 Finland
Malignant neoplasm: Upper-inner quadrant of breast
726.4
263.7
292
*
17402
ICD-8 Finland
Malignant neoplasm of breast, Glandulae
225.5
259.8
300
10
D05.9
ICD-10 Finland
Carcinoma in situ of breast, unspecified
136.3
259.8
310
17
JN4AD
NOMESCO Finland
Body CT examination
2.9
255.7
1757
4667
HA2AT
NOMESCO Finland
Cytology of mammary gland with ultrasound guidance
28.5
254.7
384
101
9703
FHL
Breast resection
10.1
252.2
556
414
HA1BA
NOMESCO Finland
Extensive X-ray mammography
16.6
250.3
445
202
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
8.8
248.0
589
503
B01AB05
ATC
enoxaparin; parenteral
1.7
246.9
6867
33856
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
15.4
245.5
448
218
C50.93
ICD-10 Finland
Malignant tumor in other specified localization in mammary gland other or unspecified histology
499.1
239.8
268
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
6.0
236.2
728
920
X19
ICPC
Breast lump/mass female
6.2
235.3
706
861
HWH99
NOMESCO Finland
Other reoperation in surgery of mammary gland
52.9
233.6
311
44
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
24.9
225.4
352
106
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
13.0
220.6
432
250
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
63.6
217.0
281
33
8522/3-C50.9
ICD-O-3
Infiltrating duct and lobular carcinoma of breast, NOS
+∞
215.4
233
*
HAD60
NOMESCO Finland
Replacement of prosthetic implant in breast
53.4
215.2
286
40
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.4
214.5
2144
7046
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
214.3
8500
45778
HA1CM
NOMESCO Finland
Mammary gland extensive MRI examination with 3 Tesla magnet
43.0
213.2
294
51
L01CA04
ATC
vinorelbine; systemic
16.0
212.3
382
179
QBE20
NOMESCO Finland
Excision and repair of scar or web of skin of trunk
11.1
208.0
437
295
A79
ICPC
Malignancy NOS
8.5
203.3
493
436
C50.30
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, no histological veryfication
1598.9
203.0
222
*
8010/3-C50.9
ICD-O-3
Carcinoma, NOS, of breast, NOS
+∞
202.5
219
*
C77.3
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes
48.4
202.3
273
42
C50.32
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, lobular tumor
335.4
199.5
226
5
8520/3-C50.2
ICD-O-3
Lobular carcinoma, NOS, of upper-inner quadrant of breast
+∞
198.8
215
*
C50.1
ICD-10 Finland
Malignant neoplasm: Central portion of breast
414.1
198.4
223
*
HA6HA
NOMESCO Finland
Tomosynthesis assessment of mammary gland specimen
73.4
193.7
246
25
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
18.7
191.0
325
130
1742A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-inner quadrant
1493.9
190.0
208
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
8.5
188.1
456
403
8480/3-C50.9
ICD-O-3
Mucinous adenocarcinoma of breast, NOS
+∞
185.8
201
*
C50.5
ICD-10 Finland
Malignant neoplasm: Lower-outer quadrant of breast
505.0
182.6
204
*
HAD50
NOMESCO Finland
Removal of prosthetic implant from breast
17.8
182.6
316
133
9706
FHL
Ablation mammae, includes axillary exploration
735.6
178.8
198
*
XX1AD
NOMESCO Finland
Other CT-examination
17.2
177.0
310
135
ZX070
NOMESCO Finland
Intensity modified radiotherapy
6.7
175.9
498
560
5702
FHL
Local lymph node removal (eg armpit, groin)
29.8
172.0
256
64
N06AX16
ATC
venlafaxine; oral
1.9
171.5
3186
13523
WF002
NOMESCO Finland
Radical radiotherapy
4.1
170.8
752
1401
X26
ICPC
Fear of breast cancer female
10.3
170.2
371
270
HA1RA
NOMESCO Finland
Combined assessment of mammary gland (mammography and ultrasound)
4.3
169.5
694
1206
L02AE02
ATC
leuprorelin; implant, parenteral
6.3
168.5
499
597
D05.0
ICD-10 Finland
Lobular carcinoma in situ
102.2
168.4
206
15
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
3.1
167.7
1025
2490
HA3ST
NOMESCO Finland
Removal of lesion of breast with radiological guidance
22.4
166.2
267
89
Z3231
NOMESCO Finland
Registered nurse
1.6
165.8
5388
27074
1749X
ICD-9 Finland
Malignant neoplasm of female breast, Breast (female), unspecified
204.6
165.5
192
7
HA4MT
NOMESCO Finland
Labeling mammary gland pathology with X-ray guidance
45.0
164.0
224
37
A02BC02
ATC
pantoprazole; systemic
1.5
163.7
13903
87084
L02AE03
ATC
goserelin; implant
7.0
158.9
434
463
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
9.3
158.3
364
293
C50.01
ICD-10 Finland
Malignant tumor of nipple and areola, ductal tumor
136.7
154.4
184
10
QXB05
NOMESCO Finland
Skin wound assessment, unspecified location
14.8
152.6
282
142
R50.9
ICD-10 Finland
Fever, unspecified
1.9
149.6
2509
10219
QBE30
NOMESCO Finland
Excision and repair of surgical scar in trunk
9.9
144.3
320
241
NK6AQ
NOMESCO Finland
Whole body bone SPET with low dose CT
51.0
143.7
192
28
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.3
142.2
1451
4775
8520/3-C50.5
ICD-O-3
Lobular carcinoma, NOS, of lower-outer quadrant of breast
+∞
139.5
151
*
8520/3-C50.8
ICD-O-3
Lobular carcinoma, NOS, of overlapping lesion of breast
+∞
139.5
151
*
8520/3-C50.1
ICD-O-3
Lobular carcinoma, NOS, of central portion of breast
+∞
139.5
151
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
138.1
2252
9060
8522/3-C50.4
ICD-O-3
Infiltrating duct and lobular carcinoma of upper-outer quadrant of breast
+∞
136.7
148
*
M05BA02
ATC
clodronic acid; systemic
22.8
136.7
218
71
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
4.6
136.2
520
841
JN4CD
NOMESCO Finland
Very extensive body CT
3.1
135.5
835
2036
Z3226
NOMESCO Finland
Physiotherapist
1.7
134.3
3806
18262
N95.1
ICD-10 Finland
Menopausal and female climacteric states
0.5
133.4
1006
14873
HAC10
NOMESCO Finland
Subcutaneous mastectomy with preservation of mamilla
35.4
130.1
186
39
L02BA02
ATC
toremifene; oral
342.4
122.9
139
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.4
122.7
659
1451
A46
ICD-10 Finland
Erysipelas
1.8
121.6
2387
10220
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.6
121.1
974
2815
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
4.7
118.4
445
708
WB610
NOMESCO Finland
Demanding neoadjuvant therapy of tumour with antibodies
148.3
118.3
140
7
C50.3
ICD-10 Finland
Malignant neoplasm: Lower-inner quadrant of breast
327.5
117.4
133
*
1748X
ICD-9 Finland
Malignant neoplasm of female breast, Other specified sites of female breast
+∞
117.3
127
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
4.7
116.4
440
704
QBJ00
NOMESCO Finland
Liposuction in trunk
8.5
113.6
273
238
ZXE00
NOMESCO Finland
One hour or less
1.4
112.1
7766
45202
ZSZ10
NOMESCO Finland
Secondary repair operation
93.0
111.9
138
11
3AA13
NOMESCO Finland
NA
26.5
111.8
171
48
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
8.0
111.2
278
259
1745A
ICD-9 Finland
Malignant neoplasm of female breast, Lower-outer quadrant
+∞
110.8
120
*
S18
ICPC
Laceration/cut
1.4
110.7
7870
45997
PJ1AN
NOMESCO Finland
Lymphsystem isotope imaging
30.6
109.2
161
39
ZXE20
NOMESCO Finland
More than three and less than five hours
1.7
108.8
2529
11390
XX1XT
NOMESCO Finland
Other puncture with other radiological guidance
17.4
107.7
187
80
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.2
106.5
1254
4394
HAA10
NOMESCO Finland
Biopsy of mammary gland
5.6
106.0
341
454
N64.9
ICD-10 Finland
Disorder of breast, unspecified
4.7
104.2
391
621
WB303
NOMESCO Finland
Simple adjuvant therapy of malignancy with biomodifiers
26.2
103.8
159
45
8500/2-C50.4
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of upper-outer quadrant of breast
+∞
103.4
112
*
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
29.5
101.5
151
38
8520/2-C50.9
ICD-O-3
Lobular carcinoma in situ, NOS, of breast, NOS
+∞
100.7
109
*
TQW99
NOMESCO Finland
Other minor procedure on skin
2.3
100.5
1025
3357
QBA00
NOMESCO Finland
Puncture of skin of trunk
12.7
99.8
196
115
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
4.7
99.6
375
598
HA1DA
NOMESCO Finland
Restricted mammography
35.1
99.3
142
30
N02AA05
ATC
oxycodone; systemic
1.7
99.1
2610
12163
N62
ICD-10 Finland
Hypertrophy of breast
2.2
98.9
1092
3716
HAF00
NOMESCO Finland
Excision of local recurrence of breast cancer
410.1
98.8
111
*
SPAT1324
SPAT
Screening procedure
0.6
98.7
2468
26829
D24
ICD-10 Finland
Benign neoplasm of breast
2.9
94.3
632
1630
C50.09
ICD-10 Finland
Malignant tumor of nipple and areola, other or undeterminated histology
257.7
91.8
105
*
N05CB02
ATC
barbiturates in combination with other drugs
2.5
91.0
777
2318
J01MA12
ATC
levofloxacin; systemic
1.6
90.1
3161
15827
B01AB10
ATC
tinzaparin; parenteral
1.9
89.5
1425
5639
XX3AT
NOMESCO Finland
Other labeling with ultrasound guidance
19.1
88.7
149
58
Z51.5
ICD-10 Finland
Palliative care
2.2
88.7
992
3391
HAD20
NOMESCO Finland
Liposuction of breast
23.4
88.1
139
44
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
5.0
87.9
311
464
J70.0
ICD-10 Finland
Acute pulmonary manifestations due to radiation
34.0
86.3
124
27
8510/3-C50.9
ICD-O-3
Medullary carcinoma, NOS, of breast, NOS
+∞
85.9
93
*
ZZQ70
NOMESCO Finland
Free microvascular graft of lymph nodes
695.0
84.9
94
*
XX9TE
NOMESCO Finland
Compementary ultrasound examination
6.9
84.8
233
252
HAD00
NOMESCO Finland
Augmentation mammoplasty
31.4
84.1
123
29
8140/3-C50.9
ICD-O-3
Adenocarcinoma, NOS, of breast, NOS
+∞
84.0
91
*
J01DB01
ATC
cefalexin; oral
1.4
83.9
16279
110000
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
3.2
82.8
492
1168
8211/3-C50.9
ICD-O-3
Tubular adenocarcinoma of breast, NOS
+∞
80.3
87
*
ZSZ00
NOMESCO Finland
Primary repair operation
102.6
79.6
97
7
WB101
NOMESCO Finland
Simple cytostatic neoadjuvant therapy
17.4
78.6
136
58
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
3.4
78.5
413
895
8503/2-C50.9
ICD-O-3
Noninfiltrating intraductal papillary adenocarcinoma of breast, NOS
+∞
78.5
85
*
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.9
77.8
1319
5328
1741A
ICD-9 Finland
Malignant neoplasm of female breast, Central portion
320.6
76.8
87
*
SPAT1269
SPAT
Other puncture and/or drainage
6.6
74.4
211
239
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.7
74.1
554
1530
WF004
NOMESCO Finland
Palliative radiotherapy
3.8
73.1
345
684
PG1BD
NOMESCO Finland
Extensive CT angiography of tissue graft, e.g. assessment of TRAN graft
108.5
72.7
88
6
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.1
72.0
900
3228
XX9AQ
NOMESCO Finland
Supplementary SPECT-CT or additional scan
28.3
71.5
107
28
WX110
NOMESCO Finland
Local anesthesy
1.3
71.3
13093
86314
B29
ICPC
Lymph/immune mech sympt/complt other
8.3
71.1
172
153
HA1S1
NOMESCO Finland
Photography of breasts
29.6
70.3
104
26
9702
FHL
Breast exploration and possible tumor removal
2.9
69.7
474
1234
1XC13
NOMESCO Finland
NA
+∞
69.2
75
*
1743A
ICD-9 Finland
Malignant neoplasm of female breast, Lower-inner quadrant
561.2
68.3
76
*
8523/3-C50.9
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of breast, NOS
+∞
68.3
74
*
8520/3-C50.3
ICD-O-3
Lobular carcinoma, NOS, of lower-inner quadrant of breast
+∞
68.3
74
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.7
68.0
1602
7184
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
6.9
67.5
185
200
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
3.1
66.6
404
973
XX2ET
NOMESCO Finland
NA
+∞
66.5
72
*
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.9
66.2
1054
4157
ZSP00
NOMESCO Finland
Procedure related to previous procedure classified in chapter P
46.5
65.2
88
14
HA1AE
SPAT
NA
2.8
64.9
447
1174
N05CF01
ATC
zopiclone; oral
1.3
64.8
6427
38694
8523/3-C50.4
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of upper-outer quadrant of breast
+∞
64.6
70
*
ZXE40
NOMESCO Finland
More than seven and less than nine hours
2.9
63.5
425
1094
D05.7
ICD-10 Finland
Other carcinoma in situ of breast
264.7
63.1
72
*
Z80.4
ICD-10 Finland
Family history of malignant neoplasm of genital organs
7.5
62.6
162
161
PD1BD
NOMESCO Finland
Extensive CT of abdominal aorta and branches
6.0
62.6
189
234
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
1.7
62.3
1383
6092
TPH04
NOMESCO Finland
Cathetrisation of vein
1.4
61.9
3477
19046
N64.5
ICD-10 Finland
Other signs and symptoms in breast
2.4
61.9
561
1727
N61
ICD-10 Finland
Inflammatory disorders of breast
2.7
61.6
469
1311
HA1ST
NOMESCO Finland
Biopsy of mammary gland with sterotactic guidance
16.5
60.9
107
48
156
Kela drug reimbursment
Lapatinib
+∞
60.9
66
*
SPAT1152
SPAT
Removal of foreign body from under the skin
2.5
60.6
539
1643
Z40.0
ICD-10 Finland
Prophylactic surgery for risk-factors related to malignant neoplasms
15.2
59.2
107
52
WC205
NOMESCO Finland
Simple therapy of local tumor recidive with hormone
486.9
59.2
66
*
OAA41
NOMESCO Finland
Health check based on individual needs
18.0
58.8
100
41
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.8
58.6
1143
4830
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
2.2
58.0
656
2252
17409
ICD-8 Finland
Malignant neoplasm of breast, Unspecified
165.0
57.3
67
*
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
4.3
56.7
232
405
PJA10
NOMESCO Finland
Exploration of lymph nodes
3.8
56.5
262
513
L01XE07
ATC
[U] lapatinib; oral
+∞
56.3
61
*
WX400
NOMESCO Finland
Inhalation anesthesy
2.0
56.1
799
3019
9719
FHL
Other measure in this category
11.4
55.8
114
74
9725
FHL
Reconstruction of the mammary gland with foreign material (after removal)
20.8
55.4
90
32
8480/3-C50.4
ICD-O-3
Mucinous adenocarcinoma of upper-outer quadrant of breast
+∞
55.4
60
*
HA1DM
NOMESCO Finland
Mammary gland very extensive MRI examination with 3 Tesla magnet
49.0
54.7
73
11
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
3.2
54.2
310
716
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.4
53.7
3244
17954
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.8
53.2
1079
4616
WB321
NOMESCO Finland
Multiple adjuvant therapy of malignancy with biomodifiers
56.7
52.9
69
9
WX704
NOMESCO Finland
Intubation
1.7
52.7
1237
5530
8507/3-C50.9
ICD-O-3
Invasive micropapillary carcinoma of breast of breast, NOS
+∞
52.6
57
*
SPAT1153
SPAT
Removal of sutures
1.3
51.9
5742
34840
C50.61
ICD-10 Finland
Malignant tumor of the scapula of the mammary gland, ductal tumor
427.5
51.8
58
*
R92
ICD-10 Finland
Abnormal findings on diagnostic imaging of breast
5.3
50.6
168
235
D05
ICD-10 Finland
Carcinoma in situ of breast
+∞
48.9
53
*
2393A
ICD-9 Finland
Neoplasm of unspecified nature, Breast
4.9
48.6
174
265
ZZS55
NOMESCO Finland
Distension of tissue expander
65.5
48.6
62
7
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.2
48.2
510
1697
TPH07
NOMESCO Finland
Cathetrisation of artery
1.6
48.2
1552
7539
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.7
47.6
2302
22593
M01AE01
ATC
ibuprofen; systemic, rectal
1.3
47.5
18136
127325
XX2VW
NOMESCO Finland
Radiologic consultation
5.4
47.4
156
216
2330A
ICD-9 Finland
Carcinoma in situ of breast and genito-urinary system, Breast
390.4
47.2
53
*
WB131
NOMESCO Finland
Very demanding neoadjuvant cytostatic therapy
56.4
46.8
61
8
D70.89
ICD-10 Finland
Neutropenic splenomegaly
3.3
46.3
250
556
Z31.6
ICD-10 Finland
General counselling and advice on procreation
7.2
45.7
120
123
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.2
45.7
492
1651
Y83.4
ICD-10 Finland
Other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
10.6
45.6
96
67
C507
ICD-10 Finland
NA
+∞
45.2
49
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
4.1
44.8
188
337
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.2
44.7
7410
47050
QCJ00
NOMESCO Finland
Liposuction in upper limb
27.1
43.9
66
18
JN5AN
NOMESCO Finland
Total body isotope imaging
37.5
43.7
61
12
1515
Kela drug reimbursment
NA
+∞
43.4
47
*
3030
Kela drug reimbursment
Abemaciclib
+∞
43.4
47
*
PJ5YQ
NOMESCO Finland
NA
+∞
43.4
47
*
C50.0
ICD-10 Finland
Malignant neoplasm: Nipple and areola
184.7
43.1
50
*
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.6
43.0
1225
5766
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.6
42.7
1280
6101
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
2.4
42.6
385
1187
JN6AD
NOMESCO Finland
CT of torso and neck
3.3
42.5
237
538
QBE00
NOMESCO Finland
Excision of loose skin or fold of skin from trunk
4.6
42.5
159
255
YX9CD
NOMESCO Finland
Other very extensive CT eamination for dose design of radiotherapy
15.8
42.4
75
35
1DB03
NOMESCO Finland
NA
180.9
42.2
49
*
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
42.0
1292
6196
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
8.4
41.9
100
88
M05BA04
ATC
alendronic acid; oral
1.5
41.7
1881
9821
HAD10
NOMESCO Finland
Augmentation of breast using prosthesis
5.7
41.7
130
169
5BX04
NOMESCO Finland
NA
76.8
41.6
52
5
8507/3-C50.4
ICD-O-3
Invasive micropapillary carcinoma of breast of upper-outer quadrant of breast
+∞
41.5
45
*
N60.9
ICD-10 Finland
Benign mammary dysplasia, unspecified
3.9
41.4
183
345
1740A
ICD-9 Finland
Malignant neoplasm of female breast, Nipple and areola
120.6
41.0
49
*
8000/3-C50.9
ICD-O-3
Neoplasm, malignant of breast, NOS
+∞
40.6
44
*
8211/3-C50.4
ICD-O-3
Tubular adenocarcinoma of upper-outer quadrant of breast
+∞
40.6
44
*
8522/3-C50.2
ICD-O-3
Infiltrating duct and lobular carcinoma of upper-inner quadrant of breast
+∞
40.6
44
*
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
0.7
40.4
1358
14180
THA00
NOMESCO Finland
Needle biopsy of mamilla
9.1
40.3
92
75
L95
ICPC
Osteoporosis
1.8
39.8
726
3000
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.4
39.4
2009
10734
8524/3-C50.9
ICD-O-3
Infiltrating lobular mixed with other types of carcinoma of breast, NOS
+∞
38.8
42
*
1BC02
NOMESCO Finland
NA
86.8
38.2
47
*
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
3.4
38.2
198
428
8524/3-C50.4
ICD-O-3
Infiltrating lobular mixed with other types of carcinoma of upper-outer quadrant of breast
+∞
37.8
41
*
L01EF03
ATC
abemaciclib; oral
+∞
37.8
41
*
9721
FHL
Mamilla reconstruction or transposition
26.3
37.8
57
16
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.5
37.5
1220
5930
N60.8
ICD-10 Finland
Other benign mammary dysplasias
4.8
37.4
134
206
9708
FHL
Radical mastectomy (Halsted), also involves removal of the parasternal gland
308.8
37.2
42
*
WW500
NOMESCO Finland
Blood transfusion
1.9
36.8
584
2300
HAA01
NOMESCO Finland
Suture of mammary gland
57.9
36.3
47
6
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.4
36.3
1882
10081
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
7.0
36.3
97
103
X79
ICPC
Benign neoplasm breast female
15.0
36.1
65
32
RD211
NOMESCO Finland
NA
1.7
35.8
763
3311
WW200
SPAT
NA
0.7
35.5
893
9857
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
2.7
35.5
265
735
A21
ICPC
Risk factor for malignancy
10.3
35.2
75
54
6500B
ICD-9 Finland
Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]
0.8
35.2
3298
29761
Z80.8
ICD-10 Finland
Family history of malignant neoplasm of other organs or systems
6.3
35.1
101
119
8500/2-C50.5
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of lower-outer quadrant of breast
+∞
35.1
38
*
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.5
34.9
1382
7017
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.2
34.9
389
1327
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
9.1
34.9
79
64
QBA10
NOMESCO Finland
Incision of skin of trunk
3.3
34.8
188
420
U07.2
ICD-10 Finland
COVID-19, virus not identified
0.7
34.6
1258
12984
M05BA06
ATC
ibandronic acid; systemic
2.0
34.5
488
1843
A08
ICPC
Swelling
1.7
34.4
740
3223
8522/3-C50.5
ICD-O-3
Infiltrating duct and lobular carcinoma of lower-outer quadrant of breast
+∞
34.1
37
*
N64.8
ICD-10 Finland
Other specified disorders of breast
4.0
34.0
145
266
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
0.7
33.9
1435
14443
QWF00
NOMESCO Finland
Reoperation for insufficiency of suture in plastic surgery of skin
28.4
33.8
50
13
Z30.2
ICD-10 Finland
Sterilization
0.7
33.8
1182
12281
HAD55
NOMESCO Finland
Incision of periprosthetic capsule of breast
26.4
33.2
50
14
G03FA14
ATC
dydrogesterone and estrogen; systemic (progestogens and estrogens, fixed comb.)
0.7
33.2
847
9328
WB201
NOMESCO Finland
Simple neoadjuvant hormone therapy of malignancy
+∞
33.2
36
*
8522/3-C50.1
ICD-O-3
Infiltrating duct and lobular carcinoma of central portion of breast
+∞
33.2
36
*
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
2.3
33.2
328
1059
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
4.6
32.7
122
196
9724
FHL
Breast augmentation or reconstruction with own tissue
13.7
32.7
61
33
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
2.5
32.4
265
775
WF099
NOMESCO Finland
Other radiotherapy
4.4
32.3
126
212
ZX001
NOMESCO Finland
Simple adjustment of radiotherapy with simulator or with therapeutic device - SSD therapy
40.6
32.2
44
8
GA5AA
NOMESCO Finland
Rib X-ray examination
5.3
32.1
106
149
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.4
32.0
289
891
QBJ99
NOMESCO Finland
Other aesthetic correction of skin of trunk
18.6
31.9
53
21
HAB30
NOMESCO Finland
Excision of mamilla or areola
17.8
31.4
53
22
N84.0
ICD-10 Finland
Polyp of corpus uteri
1.4
30.5
1822
9994
8480/3-C50.2
ICD-O-3
Mucinous adenocarcinoma of upper-inner quadrant of breast
+∞
30.5
33
*
OAB47
SPAT
NA
0.4
30.4
107
2112
T85.4
ICD-10 Finland
Mechanical complication of breast prosthesis and implant
5.9
30.2
90
112
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
0.7
30.0
792
8667
GD1AD
NOMESCO Finland
Thorax CT examination
1.8
30.0
584
2465
L90.5
ICD-10 Finland
Scar conditions and fibrosis of skin
2.9
29.8
190
479
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.3
29.6
3548
21486
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
3.3
29.5
158
352
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
0.7
29.4
926
9808
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.6
29.4
871
4136
KMAK
NOMESCO Finland
NA
0.8
29.2
7780
63659
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
3.3
28.8
154
343
335
Kela drug reimbursment
Lapatinib
+∞
28.6
31
*
8530/3-C50.9
ICD-O-3
Inflammatory carcinoma of breast, NOS
+∞
28.6
31
*
8500/2-C50.2
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of upper-inner quadrant of breast
+∞
28.6
31
*
C50.02
ICD-10 Finland
Malignant tumor of nipple and areola, lobular tumor
86.1
28.5
35
*
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
6.3
28.4
81
95
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
7.3
28.3
73
74
PD1AD
NOMESCO Finland
CT of abdominal aorta and branches
5.1
28.3
96
140
ZXA10
NOMESCO Finland
Bilateral
1.3
28.2
3282
19793
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
0.7
28.1
1239
12409
J94.8
ICD-10 Finland
Other specified pleural conditions
2.7
28.1
208
576
O24.4
ICD-10 Finland
Diabetes mellitus arising in pregnancy
0.6
27.6
396
4950
Z02.4
ICD-10 Finland
Examination for driving licence
1.3
27.5
2390
13873
A14AB01
ATC
nandrolone; parenteral
6.4
27.3
77
89
T81.9
ICD-10 Finland
Unspecified complication of procedure
2.2
27.1
293
989
G03DA02
ATC
medroxyprogesterone; systemic (pregnen (4) derivatives)
1.3
27.0
2305
13344
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.3
26.9
1988
11269
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
3.2
26.8
152
354
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.2
26.4
6889
45086
PJ4AT
NOMESCO Finland
Labeling lymphnode with ultrasound guidance
15.1
26.4
47
23
SAA01
NOMESCO Finland
Simple examination of mouth
0.9
26.2
11594
91505
Z44.3
ICD-10 Finland
Fitting and adjustment of external breast prosthesis
114.4
26.0
31
*
ZZR00
NOMESCO Finland
Flap of skin
2.0
25.9
339
1242
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
3.1
25.8
151
359
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.2
25.6
8723
58348
SPAT1283
SPAT
Restricted health certificate
0.8
25.4
1574
15021
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
0.9
25.4
7197
58840
NK6SN
NOMESCO Finland
Bone SPECT
21.1
25.2
40
14
LGA21
NOMESCO Finland
Laparoscopic sterilisation by constriction of Fallopian tubes
0.7
25.0
650
7137
ZXC90
NOMESCO Finland
Use of absorbable mesh in surgery
48.6
25.0
33
5
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.9
25.0
403
1601
S76
ICPC
Skin infection other
1.6
24.9
720
3397
8401/3-C50.9
ICD-O-3
Apocrine adenocarcinoma of breast, NOS
+∞
24.9
27
*
8500/2-C50.3
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of lower-inner quadrant of breast
+∞
24.9
27
*
8211/3-C50.2
ICD-O-3
Tubular adenocarcinoma of upper-inner quadrant of breast
+∞
24.9
27
*
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.2
24.8
4065
25426
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
1.8
24.8
487
2063
Z30.1
ICD-10 Finland
Insertion of (intrauterine) contraceptive device
0.7
24.7
643
7057
A04AA03
ATC
tropisetron; systemic
4.2
24.5
98
171
C79.2
ICD-10 Finland
Secondary malignant neoplasm of skin
10.5
24.5
51
36
C79.39
ICD-10 Finland
Secondary malignant tumor of the meninges, ventricle or other part of the brain
9.5
24.3
53
41
WE200
NOMESCO Finland
Profylactive therapy of malignancy with hormones
107.0
24.2
29
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.4
24.1
1196
6340
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
2.0
24.0
343
1301
SPAT1211
SPAT
Application of soft bandage
1.4
23.8
1394
7609
WB600
NOMESCO Finland
Neoadjuvant therapy of primary tumour with antibodies
31.3
23.7
34
8
SGA01
NOMESCO Finland
Tooth opening as first aid
0.8
23.7
1480
14114
SPAT1308
SPAT
Sexual health counselling
0.6
23.7
456
5325
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.4
23.6
1253
6725
6117B
ICD-9 Finland
Other disorders of breast, Signs and symptoms in breast[TUMOR MAMMAE]
3.0
23.5
146
364
R93.5
ICD-10 Finland
Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum
2.0
23.5
316
1173
8097/3-C44.3
ICD-O-3
Basal cell carcinoma, nodular of skin of other and unspecified parts of face
18.0
23.4
39
16
E66.8
ICD-10 Finland
Other obesity
0.6
23.3
390
4696
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
2.3
23.2
225
722
E66.01
ICD-10 Finland
Obesity due to excess calories
0.7
23.2
663
7150
1XC14
NOMESCO Finland
NA
+∞
23.1
25
*
TQW40
NOMESCO Finland
Remowal of suture of skin
1.4
22.7
1136
6032
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
4.6
22.6
83
133
Z08
ICD-10 Finland
Follow-up examination after treatment for malignant neoplasms
12.2
22.2
43
26
HAD57
NOMESCO Finland
Resection of periprosthetic capsule of breast
16.5
22.1
38
17
8543/3-C50.9
ICD-O-3
Paget disease and intraductal carcinoma of breast of breast, NOS
+∞
22.1
24
*
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
6.6
22.0
60
67
ZZS50
NOMESCO Finland
Insertion of tissue expander
32.7
21.9
31
7
J01CE08
ATC
benzathine benzylpenicillin; parenteral
2.7
21.8
161
448
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
2.5
21.7
176
516
HAC99
NOMESCO Finland
Other mastectomy
184.5
21.7
25
*
Z2221
NOMESCO Finland
Medical doctor
1.2
21.3
4750
30531
8500/2-C50.1
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of central portion of breast
+∞
21.2
23
*
8522/3-C50.8
ICD-O-3
Infiltrating duct and lobular carcinoma of overlapping lesion of breast
+∞
21.2
23
*
WX290
NOMESCO Finland
Other blockade of nerve
0.9
21.2
5744
47313
N05BA04
ATC
oxazepam; oral
1.2
21.1
4525
28980
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
0.7
21.1
762
7889
XX9CN
NOMESCO Finland
NA
35.6
20.9
29
6
R83
ICPC
Respiratory infection other
0.8
20.8
2628
23139
HA1AA
SPAT
NA
2.0
20.8
274
1010
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
0.9
20.7
8917
71098
N92.0
ICD-10 Finland
Excessive and frequent menstruation with regular cycle
0.7
20.7
1115
10861
N95.2
ICD-10 Finland
Postmenopausal atrophic vaginitis
1.3
20.7
1415
7918
E0000UV
ATC
NA
1.2
20.7
7121
47412
L02AB02
ATC
medroxyprogesterone; systemic (progestogens)
2.7
20.7
152
421
9710
FHL
Existence of a relapse
92.2
20.6
25
*
Z32.1
ICD-10 Finland
Pregnancy confirmed
0.6
20.5
346
4156
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
5.4
20.5
65
89
ZXD20
NOMESCO Finland
Day surgery
1.3
20.4
2258
13495
8510/3-C50.4
ICD-O-3
Medullary carcinoma, NOS, of upper-outer quadrant of breast
+∞
20.3
22
*
8480/3-C50.5
ICD-O-3
Mucinous adenocarcinoma of lower-outer quadrant of breast
+∞
20.3
22
*
8575/3-C50.9
ICD-O-3
Metaplastic carcinoma, NOS, of breast, NOS
+∞
20.3
22
*
HA1RA
SPAT
NA
1.6
20.0
482
2172
LCA06
NOMESCO Finland
Biopsy of endometrium
1.2
19.8
2864
17641
SPAT1193
SPAT
Pap smear
0.7
19.7
1033
10103
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
7.1
19.7
51
53
L04AX01
ATC
azathioprine; systemic
0.6
19.6
261
3323
M81.9
ICD-10 Finland
Osteoporosis, unspecified
1.5
19.6
774
3929
1CD01
NOMESCO Finland
NA
5.3
19.6
63
88
HA1AT
SPAT
NA
8.5
19.5
45
39
M03BC01
ATC
orphenadrine (citrate); systemic
0.8
19.5
3144
27063
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
1.5
19.4
768
3895
8480/3-C50.1
ICD-O-3
Mucinous adenocarcinoma of central portion of breast
+∞
19.4
21
*
8246/3-C50.9
ICD-O-3
Neuroendocrine carcinoma, NOS, of breast, NOS
+∞
19.4
21
*
G43
ICD-10 Finland
Migraine
0.6
19.3
246
3167
L58.9
ICD-10 Finland
Radiodermatitis, unspecified
22.1
19.3
30
10
M54.4
ICD-10 Finland
Lumbago with sciatica
0.8
19.2
2028
18197
MCA10
NOMESCO Finland
Lower uterine segment caesarean section
0.7
19.2
705
7281
X18
ICPC
Breast pain female
1.9
19.0
271
1032
MA2AE
NOMESCO Finland
Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus
0.7
18.9
599
6346
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
0.6
18.9
382
4415
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
4.0
18.9
80
149
QX4YT
NOMESCO Finland
Puncture of superficial collection under ultrasound guidance
5.0
18.7
63
93
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
0.5
18.5
149
2178
G03DC05
ATC
[U] tibolone; oral
1.4
18.5
1061
5773
M77.1
ICD-10 Finland
Lateral epicondylitis
0.7
18.5
616
6465
8401/3-C50.4
ICD-O-3
Apocrine adenocarcinoma of upper-outer quadrant of breast
+∞
18.5
20
*
8523/3-C50.5
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of lower-outer quadrant of breast
+∞
18.5
20
*
NF3AA
NOMESCO Finland
Femur X-ray examination
1.9
18.5
276
1069
MA5AE
NOMESCO Finland
Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation
0.2
18.4
14
616
L09
ICPC
Arm symptom/complaint
1.5
18.3
673
3365
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
1.6
18.2
486
2251
SPAT1379
SPAT
Health check-up of pregnant person
0.5
18.2
189
2565
G03FB06
ATC
medroxyprogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)
1.2
18.2
2170
13072
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.2
18.1
2314
14046
QBE35
NOMESCO Finland
Repair of skin defect in trunk after surgery or injury
6.4
18.0
50
58
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
2.8
18.0
121
319
C49.39
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thorax other or unspecified tumor
19.4
18.0
29
11
ZZR70
NOMESCO Finland
Perforator flaps
24.9
18.0
27
8
ZXC82
NOMESCO Finland
Microsurgical
11.7
17.9
35
22
R60.0
ICD-10 Finland
Localized oedema
1.3
17.9
1744
10249
M53.1
ICD-10 Finland
Cervicobrachial syndrome
0.8
17.9
1237
11660
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
2.2
17.9
189
636
A41.9
ICD-10 Finland
Sepsis, unspecified
1.7
17.8
394
1735
XX9XW
NOMESCO Finland
NA
3.0
17.8
106
258
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.5
17.7
609
3000
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.3
17.6
1464
8426
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
4.1
17.5
72
131
5BA08
NOMESCO Finland
NA
3.1
17.5
102
246
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
0.7
17.5
474
5163
G47.3
ICD-10 Finland
Sleep apnoea
0.8
17.4
1930
17243
TQX05
NOMESCO Finland
Skin puncture, unspecified location
4.9
17.4
60
91
TPX15
NOMESCO Finland
Removal of vascular injection port
3.4
17.4
88
191
HAB20
NOMESCO Finland
Excision of lactiferous duct
3.4
17.4
88
191
W78
ICPC
Pregnancy
0.6
17.2
330
3849
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
2.6
17.1
130
368
2170A
ICD-9 Finland
Benign neoplasm of breast[NEOPLASMA BENIGNUM MAMMAE]
2.4
17.1
147
448
X62
ICPC
Female Genital, Administrative procedure
54.1
17.1
22
*
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
0.5
16.8
139
2015
H25.1
ICD-10 Finland
Senile nuclear cataract
1.2
16.8
4043
26076
G02BA03
ATC
plastic IUD with progestogen
0.8
16.8
1606
14578
Z39.2
ICD-10 Finland
Routine postpartum follow-up
0.7
16.7
401
4468
8507/3-C50.5
ICD-O-3
Invasive micropapillary carcinoma of breast of lower-outer quadrant of breast
+∞
16.6
18
*
N05BA06
ATC
lorazepam; systemic, sublingual
1.4
16.5
735
3819
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
3.0
16.5
101
252
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
3.3
16.4
86
192
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
0.7
16.4
544
5712
HA1DT
NOMESCO Finland
Mammary gland biopsy with MRI guidance
40.6
16.3
22
*
M75.1
ICD-10 Finland
Rotator cuff syndrome
0.8
16.3
3065
26092
L02AB01
ATC
megestrol; oral (progestogens)
140.1
16.3
19
*
L03.3
ICD-10 Finland
Cellulitis of trunk
2.7
16.3
118
326
WE100
NOMESCO Finland
Profylactic cytostatic therapy
13.0
16.2
30
17
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
0.8
16.1
1586
14353
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.9
16.1
6991
56046
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
1.6
16.1
398
1812
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.2
16.0
4899
32188
XX9KE
NOMESCO Finland
Ultrasound examination with contrast
9.2
16.0
35
28
SPAT1380
SPAT
Postpartum check-up
0.5
15.9
145
2038
A26
ICPC
Fear of cancer, NOS
2.9
15.9
100
254
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
0.8
15.8
1573
14215
QWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in surgery of skin
4.0
15.7
66
123
9020/3-C50.9
ICD-O-3
Phyllodes tumor, malignant of breast, NOS
+∞
15.7
17
*
8504/2-C50.9
ICD-O-3
Encapsulated papillary carcinoma of breast, NOS
+∞
15.7
17
*
8523/3-C50.2
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of upper-inner quadrant of breast
+∞
15.7
17
*
A02BC05
ATC
esomeprazole; systemic
1.1
15.7
7705
52295
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
3.0
15.6
95
236
JDF11
NOMESCO Finland
Laparoscopic gastric bypass
0.4
15.5
65
1187
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
0.5
15.5
152
2094
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
0.7
15.4
405
4438
Z34.9
ICD-10 Finland
Supervision of normal pregnancy, unspecified
0.7
15.3
561
5798
B04
ICPC
Blood symptom/complaint
3.2
15.3
84
195
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
1.7
15.3
339
1498
B01AB04
ATC
dalteparin; parenteral
1.4
15.2
728
3840
ZX050
NOMESCO Finland
Stereotactic radiotherapy
3.1
15.2
87
208
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
2.1
15.1
169
584
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.3
15.0
1138
6465
MA3AE
NOMESCO Finland
Combined first trimester screening
0.2
15.0
17
583
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
1.5
15.0
511
2516
J01FF01
ATC
clindamycin; systemic
1.2
15.0
4392
28739
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
0.7
14.8
340
3820
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
0.8
14.8
2666
22790
HA5CB
NOMESCO Finland
Galactography
3.8
14.8
64
123
3002
Kela drug reimbursment
Ribociclib
+∞
14.8
16
*
8541/3-C50.9
ICD-O-3
Paget disease and infiltrating duct carcinoma of breast of breast, NOS
+∞
14.8
16
*
8503/3-C50.4
ICD-O-3
Intraductal papillary adenocarcinoma with invasion of upper-outer quadrant of breast
+∞
14.8
16
*
8575/3-C50.4
ICD-O-3
Metaplastic carcinoma, NOS, of upper-outer quadrant of breast
+∞
14.8
16
*
8503/3-C50.9
ICD-O-3
Intraductal papillary adenocarcinoma with invasion of breast, NOS
+∞
14.8
16
*
ZZQ60
NOMESCO Finland
Free microvascular graft of nerve
+∞
14.8
16
*
1514
Kela drug reimbursment
NA
+∞
14.8
16
*
8480/3-C50.3
ICD-O-3
Mucinous adenocarcinoma of lower-inner quadrant of breast
+∞
14.8
16
*
J05AB11
ATC
valaciclovir; oral
1.2
14.6
2235
13813
C50.69
ICD-10 Finland
Malignant tumor of the scapula of the mammary gland, other or undeterminated histology
125.3
14.5
17
*
C50.62
ICD-10 Finland
Malignant tumor of the scapula of the mammary gland, lobular tumor
125.3
14.5
17
*
WD215
NOMESCO Finland
Multiple therapy of methastized malignancy with hormones
10.1
14.4
30
22
N60.1
ICD-10 Finland
Diffuse cystic mastopathy
2.1
14.4
173
618
HAA00
NOMESCO Finland
Incision of mammary gland
5.2
14.4
46
65
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
3.8
14.3
63
123
N05CF02
ATC
zolpidem; oral
1.2
14.3
3194
20445
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.8
14.3
1184
10921
Y84.9
ICD-10 Finland
Medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.0
14.2
86
213
21899
ICD-8 Finland
Uterine fibroma
1.3
14.2
916
5080
WE198
NOMESCO Finland
Palliative cystotatic therapy
9.1
14.2
31
25
S04
ICPC
Lump/swelling localized
1.3
14.1
1329
7778
P01BA02
ATC
hydroxychloroquine; oral
0.8
14.1
1044
9761
MA1AE
NOMESCO Finland
Ultrasound examination of early pregnancy (before 12. postmenstrual week)
0.7
14.1
426
4542
WB323
NOMESCO Finland
Demanding adjuvant therapy of malignancy with biomodifiers
7.9
13.9
33
31
8507/3-C50.1
ICD-O-3
Invasive micropapillary carcinoma of breast of central portion of breast
+∞
13.8
15
*
8524/3-C50.2
ICD-O-3
Infiltrating lobular mixed with other types of carcinoma of upper-inner quadrant of breast
+∞
13.8
15
*
8500/2-C50.8
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of overlapping lesion of breast
+∞
13.8
15
*
1744A
ICD-10 Finland
NA
+∞
13.8
15
*
SFA10
NOMESCO Finland
Fillning on one surface of tooth
0.9
13.8
8117
64103
103
Kela drug reimbursment
Diabetes, insulin-treated
0.9
13.8
2845
24067
ZX100
NOMESCO Finland
Oral
2.0
13.8
177
650
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
0.3
13.7
32
750
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
0.9
13.7
2959
24944
R06AE07
ATC
cetirizine; oral
1.1
13.7
8326
57100
C03CA01
ATC
furosemide; systemic
1.2
13.7
4275
28077
NK6PA
NOMESCO Finland
Measurement of bone density from one location with X-ray
3.2
13.7
73
167
WB213
NOMESCO Finland
Adjuvant hormone therapy of malignancy
118.0
13.6
16
*
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
1.4
13.6
749
4052
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
1.4
13.5
716
3843
G43.9
ICD-10 Finland
Migraine, unspecified
0.7
13.5
467
4868
A10AA02
ATC
NA
0.6
13.5
161
2101
TLC00
NOMESCO Finland
Insertion of intrauterine device
0.7
13.4
617
6151
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.2
13.4
2962
18932
Z10.0
ICD-10 Finland
Occupational health examination
0.7
13.4
348
3815
T80.8
ICD-10 Finland
Other complications following infusion, transfusion and therapeutic injection
6.2
13.3
37
44
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
3.0
13.3
78
191
Z2446
NOMESCO Finland
Social worker
1.3
13.3
825
4551
ZXH09
SPAT
NA
0.5
13.3
88
1364
S29
ICPC
Skin symptom/complaint other
1.2
13.2
2581
16318
K02.1
ICD-10 Finland
Caries of dentine
0.9
13.1
8453
66493
SPAT1197
SPAT
Extensive health check-up of expecting family
0.6
13.1
287
3255
A07EC01
ATC
sulfasalazine; oral, rectal
0.8
13.1
802
7678
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
0.7
13.1
525
5340
WC401
NOMESCO Finland
Simple antibody therapy of local recurrence of tumour
9.4
13.1
28
22
ZX121
NOMESCO Finland
Central venous catheter
3.2
12.9
70
162
8523/3-C50.8
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of overlapping lesion of breast
+∞
12.9
14
*
8201/3-C50.9
ICD-O-3
Cribriform carcinoma, NOS, of breast, NOS
+∞
12.9
14
*
1XC0V
NOMESCO Finland
NA
+∞
12.9
14
*
O04.9
ICD-10 Finland
Medical abortion, complete or unspecified, without complication
0.7
12.9
570
5713
I42.7
ICD-10 Finland
Cardiomyopathy due to drugs and other external agents
12.6
12.9
24
14
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
4.1
12.9
51
91
OAB43
SPAT
NA
0.8
12.8
1552
13759
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
1.7
12.8
294
1314
T89
ICPC
Diabetes insulin dependent
0.6
12.7
161
2067
WB221
NOMESCO Finland
Demanding neoadjuvant hormone therapy of malignancy
110.6
12.7
15
*
9829
FHL
Other measure in this category
59.0
12.7
16
*
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
1.7
12.6
289
1293
A87
ICPC
Complication of medical treatment
2.3
12.6
122
398
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
0.5
12.5
87
1325
R03AC02
ATC
salbutamol; inhalant
0.9
12.4
8753
68598
K04.0
ICD-10 Finland
Pulpitis
0.8
12.4
769
7350
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
0.6
12.4
195
2374
PJW20
NOMESCO Finland
Lymphovenous shunt
18.4
12.4
20
8
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
0.8
12.4
993
9196
WX725
NOMESCO Finland
Noninvasive ventilation
1.4
12.3
594
3141
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
2.1
12.2
139
487
W12
ICPC
Contraception intrauterine
0.7
12.2
512
5174
N03AG01
ATC
valproic acid; systemic, rectal
0.7
12.2
451
4648
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
1.8
12.2
197
792
LCB98
NOMESCO Finland
Other transluminal endoscopic excision of lesion of uterus
1.9
12.1
175
675
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
0.7
12.1
561
5586
Y16
ICPC
Breast symptom/complaint male
31.3
12.1
17
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.2
12.0
1388
8327
HAF99
NOMESCO Finland
Other operation for local recurrence of breast cancer
+∞
12.0
13
*
8523/3-C50.1
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of central portion of breast
+∞
12.0
13
*
173
Kela drug reimbursment
Trastuzumab injection
+∞
12.0
13
*
00044
NOMESCO Finland
NA
+∞
12.0
13
*
8507/3-C50.2
ICD-O-3
Invasive micropapillary carcinoma of breast of upper-inner quadrant of breast
+∞
12.0
13
*
O82.0
ICD-10 Finland
Delivery by elective caesarean section
0.7
11.9
279
3119
B02.9
ICD-10 Finland
Zoster without complication
1.3
11.9
848
4778
ZXF00
NOMESCO Finland
Interruption caused by intraoperative deterioration of general condition
3.2
11.8
63
145
N06AX11
ATC
mirtazapine; oral
1.1
11.8
5667
38234
ZX000
NOMESCO Finland
Simple adjustment of radiotherapy with simulator or with therapeutic device - isocentric therapy
12.5
11.8
22
13
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.2
11.8
2072
12971
A07AA02
ATC
nystatin; oral
1.3
11.8
1040
6038
A03CA05
ATC
glycopyrronium bromide and psycholeptics; systemic
1.8
11.7
191
769
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.3
11.7
1145
6733
QWA00
NOMESCO Finland
Repair of wound dehiscence in surgery of skin
2.7
11.7
80
216
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
0.8
11.7
876
8182
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
2.4
11.7
100
307
M54.5
ICD-10 Finland
Low back pain
0.9
11.7
4831
39032
Y69
ICD-10 Finland
Unspecified misadventure during surgical and medical care
2.0
11.7
157
591
EB1AA
NOMESCO Finland
Tooth X-ray examination
0.9
11.6
8810
68873
SGA04
NOMESCO Finland
Very demanding opening and dilatation of root canal of tooth
0.8
11.6
978
9005
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
2.1
11.5
127
439
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
1.7
11.5
229
983
NB6AA
NOMESCO Finland
Humerus X-ray examination
1.6
11.5
297
1370
LCB25
NOMESCO Finland
Hysteroscopic excision of lesion
1.3
11.5
1002
5807
M01AX05
ATC
glucosamine; oral
1.1
11.4
3906
25775
N05AX08
ATC
risperidone; systemic
0.7
11.4
613
5972
F43.29
ICD-10 Finland
Adaptation disorder UNS
1.6
11.4
278
1264
OAA80
SPAT
NA
0.6
11.4
156
1960
R31
NOMESCO Finland
Adaptation training
4.8
11.3
38
58
M03BX02
ATC
tizanidine; oral
0.9
11.2
10976
84796
L82
ICD-10 Finland
Seborrhoeic keratosis
1.2
11.2
2615
16773
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
5.7
11.2
33
43
G56.0
ICD-10 Finland
Carpal tunnel syndrome
0.8
11.2
1833
15815
SGC00
NOMESCO Finland
Local medication of root channels of tooth
0.8
11.2
1006
9195
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
1.8
11.2
192
790
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
0.9
11.1
2406
20308
SPAT1192
SPAT
Gynaecological examination
0.8
11.1
713
6785
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
1.9
11.1
167
656
ZX002
NOMESCO Finland
Simple dose design for radiotherapy based on tomography - isocentric therapy
11.9
11.1
21
13
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.5
11.1
378
1867
A10AA01
ATC
NA
0.5
11.1
111
1513
8530/3-C50.4
ICD-O-3
Inflammatory carcinoma of upper-outer quadrant of breast
+∞
11.1
12
*
HAF10
NOMESCO Finland
Repair after excision of local recurrence of breast cancer using graft or flap
+∞
11.1
12
*
185
Kela drug reimbursment
docetaxel
+∞
11.1
12
*
8201/3-C50.4
ICD-O-3
Cribriform carcinoma, NOS, of upper-outer quadrant of breast
+∞
11.1
12
*
9120/3-C50.9
ICD-O-3
Hemangiosarcoma of breast, NOS
+∞
11.1
12
*
C50.60
ICD-10 Finland
Malignant tumor of the scapula of the mammary gland, no histological veryfication
+∞
11.1
12
*
C05.1
ICD-10 Finland
Malignant neoplasm: Soft palate
8.4
11.1
25
22
HAD35
NOMESCO Finland
Reduction mammoplasty with transplantation of areola
4.2
11.0
42
73
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
3.2
11.0
58
133
-1
ICD-10 Finland
NA
1.4
10.9
482
2511
1746A
ICD-9 Finland
Malignant neoplasm of female breast, Axillary tail
95.8
10.9
13
*
HA3RT
NOMESCO Finland
Coagulation of mammary neoplasm under radiological guidance
7.1
10.8
27
28
L71
ICPC
Malignant neoplasm musculoskeletal
8.0
10.8
25
23
Z37.0
ICD-10 Finland
Single live birth
0.7
10.8
517
5115
N02AJ06
ATC
codeine and paracetamol; systemic
1.1
10.8
6112
41595
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.3
10.7
790
4476
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
1.4
10.7
493
2588
G03DB02
ATC
megestrol; oral (pregnadien derivatives)
1.3
10.7
933
5408
L88
ICPC
Rheumatoid/seropositive arthritis
0.7
10.7
355
3722
G03FB05
ATC
norethisterone and estrogen; systemic (progestogens and estrogens, sequential prep.)
1.2
10.7
2692
17371
MA2DE
NOMESCO Finland
Detailed ultrasound examination of fetus including color doppler method
0.7
10.7
331
3512
Z36.0
ICD-10 Finland
Antenatal screening for chromosomal anomalies
0.6
10.7
213
2457
6101A
ICD-9 Finland
Benign mammary dysplasias, Diffuse cystic mastopathy
2.3
10.6
98
314
C78.1
ICD-10 Finland
Secondary malignant neoplasm of mediastinum
6.9
10.6
27
29
G03CA04
ATC
estriol; systemic, vaginal
1.2
10.6
1640
10148
N03AX09
ATC
lamotrigine; oral
0.7
10.5
305
3272
ZYC01
SPAT
NA
0.7
10.5
381
3935
N95.0
ICD-10 Finland
Postmenopausal bleeding
1.2
10.5
1976
12446
N92.1
ICD-10 Finland
Excessive and frequent menstruation with irregular cycle
0.8
10.5
591
5719
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
2.2
10.5
112
383
SPAT1317
SPAT
Planned health check-up monitoring, health check-up performed based on individual need
0.7
10.5
547
5348
SPAT1190
SPAT
Insertion or removal of intrauterine contraceptive device
0.7
10.4
273
2985
Z12.4
ICD-10 Finland
Special screening examination for neoplasm of cervix
0.6
10.4
188
2215
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.2
10.4
1666
10340
SGB20
NOMESCO Finland
Filling of root of tooth with 2 root channels
0.7
10.4
467
4665
WX707
NOMESCO Finland
Fiberoscopic intubation
3.2
10.4
54
123
OAB39
NOMESCO Finland
Sexual health guidance
12.7
10.4
19
11
OAB42
SPAT
NA
0.7
10.3
297
3192
N39.3
ICD-10 Finland
Stress incontinence
0.8
10.3
1146
10247
E66.00
ICD-10 Finland
Metabolic syndrome
0.7
10.3
382
3931
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
3.6
10.3
46
93
N02AA01
ATC
morphine; systemic, rectal
2.1
10.3
120
427
OAB44
SPAT
NA
0.6
10.3
199
2309
L04
ICPC
Chest symptom/complaint
1.3
10.2
814
4663
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
2.8
10.2
65
170
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
0.9
10.2
6118
48511
2180A
ICD-9 Finland
Uterine leiomyoma, Submucous leiomyoma of uterus
1.2
10.2
1162
6961
N81.2
ICD-10 Finland
Incomplete uterovaginal prolapse
0.8
10.2
714
6717
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
1.9
10.2
153
602
LBE01
NOMESCO Finland
Laparoscopic salpingectomy
0.6
10.2
153
1879
8211/3-C50.5
ICD-O-3
Tubular adenocarcinoma of lower-outer quadrant of breast
+∞
10.1
11
*
8509/2-C50.9
ICD-O-3
Solid papillary carcinoma in situ of breast, NOS
+∞
10.1
11
*
8500/3-C50.0
ICD-O-3
Infiltrating duct carcinoma, NOS, of nipple
+∞
10.1
11
*
L01EH01
ATC
lapatinib; oral
+∞
10.1
11
*
9680/3-C50.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of breast, NOS
+∞
10.1
11
*
8543/3-C50.1
ICD-O-3
Paget disease and intraductal carcinoma of breast of central portion of breast
+∞
10.1
11
*
Z34.0
ICD-10 Finland
Supervision of normal first pregnancy
0.8
10.1
546
5316
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
0.7
10.1
494
4875
H81
ICPC
Excessive ear wax
1.2
10.1
2096
13314
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
0.8
10.1
695
6552
J70.1
ICD-10 Finland
Chronic and other pulmonary manifestations due to radiation
13.3
10.0
18
10
C49.30
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thorax without histology
13.3
10.0
18
10
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
2.7
10.0
67
181
M81.0
ICD-10 Finland
Postmenopausal osteoporosis
1.4
10.0
495
2636
L04AB04
ATC
adalimumab; parenteral
0.5
10.0
86
1221
E66
ICD-10 Finland
Obesity
0.7
9.9
333
3482
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
1.8
9.9
157
630
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
0.9
9.9
5336
42561
D19
ICPC
Teeth/gum symptom/complaint
0.9
9.9
3486
28484
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
0.8
9.9
542
5261
L04AA06
ATC
mycophenolic acid; systemic
0.5
9.9
57
921
SAA02
NOMESCO Finland
Basic examination of mouth
0.9
9.9
10431
80520
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
1.9
9.8
148
581
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
1.3
9.8
822
4741
A10AE04
ATC
insulin glargine; parenteral
0.8
9.8
663
6268
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
0.8
9.8
1200
10632
R03DC03
ATC
montelukast; oral
0.9
9.7
2202
18533
N89
ICPC
Migraine
0.6
9.7
146
1793
N81.6
ICD-10 Finland
Rectocele
0.8
9.7
1070
9574
PD2BD
NOMESCO Finland
Extensive CT angiography of pelvic organs
10.8
9.7
19
13
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
3.3
9.7
48
106
M54.2
ICD-10 Finland
Cervicalgia
0.8
9.7
698
6543
A10AE05
ATC
insulin detemir; parenteral
0.7
9.7
334
3474
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.2
9.7
1623
10117
N81.1
ICD-10 Finland
Cystocele
0.8
9.6
1075
9605
J05AB01
ATC
aciclovir; systemic
1.1
9.6
3717
24704
-54
ICPC
Repair/fix-suture/cast/prosth device
1.5
9.6
333
1655
L04AA13
ATC
leflunomide; oral
0.7
9.6
220
2463
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
3.3
9.6
49
111
9705
FHL
Subcutaneous mastectomy
8.6
9.5
21
18
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
0.8
9.5
1101
9801
215
Kela drug reimbursment
Diabetes, non-insulin-treated
0.9
9.5
2630
21822
J01.0
ICD-10 Finland
Acute maxillary sinusitis
0.9
9.4
3163
25930
9844
FHL
Musculocutaneous tongue
31.9
9.4
13
*
LBE20
NOMESCO Finland
Laparoscopic bilateral salpingectomy
0.4
9.4
35
666
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
1.7
9.4
190
826
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
0.6
9.3
149
1803
N05AX12
ATC
aripiprazole; systemic
0.6
9.3
174
2034
K08.80
ICD-10 Finland
Toothache NOS
0.8
9.3
797
7325
8523/3-C50.3
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of lower-inner quadrant of breast
+∞
9.2
10
*
8522/3-C50.3
ICD-O-3
Infiltrating duct and lobular carcinoma of lower-inner quadrant of breast
+∞
9.2
10
*
8540/3-C50.0
ICD-O-3
Paget disease, mammary of nipple
+∞
9.2
10
*
HAD41
NOMESCO Finland
Transposition of areola
+∞
9.2
10
*
RF190
NOMESCO Finland
NA
8.7
9.1
20
17
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
8.7
9.1
20
17
N05CD07
ATC
temazepam; oral
1.2
9.1
1934
12303
C50.6
ICD-10 Finland
Malignant neoplasm: Axillary tail of breast
81.1
9.1
11
*
HA1CG
SPAT
NA
20.6
9.1
14
5
SGB30
NOMESCO Finland
Other demanding filling of root channel of tooth
0.8
9.1
1028
9180
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
0.5
9.1
81
1141
ZXF20
NOMESCO Finland
Interruption caused by problems of surgical technique
4.7
9.1
31
49
A40.8
ICD-10 Finland
Other streptococcal sepsis
2.4
9.1
77
238
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
1.6
9.0
231
1069
S93.4
ICD-10 Finland
Sprain and strain of ankle
0.8
9.0
914
8251
SPAT1229
SPAT
Assessment of need for aid
1.2
9.0
1187
7223
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.7
9.0
227
2496
ULC02
NOMESCO Finland
Hysteroscopy
1.2
9.0
1076
6480
S21
ICPC
Skin texture symptom/complaint
1.2
9.0
1753
11075
Z35.2
ICD-10 Finland
Supervision of pregnancy with other poor reproductive or obstetric history
0.4
9.0
48
797
C77.9
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph node, unspecified
5.0
9.0
29
43
H04AA01
ATC
glucagon; nasal, parenteral
0.5
9.0
63
951
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
0.9
9.0
6254
49295
1AA01
NOMESCO Finland
NA
5.4
8.9
27
37
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.2
8.9
1890
12021
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
0.7
8.9
362
3666
R74
ICPC
Upper respiratory infection acute
0.9
8.9
3723
30134
L04AB01
ATC
etanercept; parenteral
0.5
8.8
71
1030
O36.6
ICD-10 Finland
Maternal care for excessive fetal growth
0.6
8.8
131
1610
K11.71
ICD-10 Finland
Xerostomy (dry mouth)
1.7
8.8
167
713
R5110
SPAT
NA
1.4
8.8
356
1827
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
0.8
8.8
671
6245
XMA22
NOMESCO Finland
General examination of pregnant woman
0.7
8.8
330
3383
WGA10
NOMESCO Finland
Measurement of pain intensity
7.4
8.7
21
21
O13
ICD-10 Finland
Gestational [pregnancy-induced] hypertension
0.7
8.7
238
2575
NA049
NOMESCO Finland
Radiotherapy of methastasis in spine
9.5
8.7
18
14
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
2.1
8.7
100
358
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
0.4
8.6
26
540
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
0.5
8.6
65
961
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.2
8.6
90
308
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
1.3
8.6
592
3324
O99.80
ICD-10 Finland
The fear of childbirth
0.6
8.6
171
1968
O03.1
ICD-10 Finland
Spontaneous abortion, Incomplete, complicated by delayed or excessive haemorrhage
0.5
8.5
52
822
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.2
8.5
2159
13927
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
1.8
8.5
135
543
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
2.9
8.5
51
130
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
1.6
8.5
244
1164
9729
FHL
Other measure in this category
2.5
8.5
64
186
M01AH05
ATC
etoricoxib; oral
0.9
8.5
10387
79904
WZA10
NOMESCO Finland
Long statement of health and health related matters
1.7
8.5
186
828
O10.0
ICD-10 Finland
Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium
0.5
8.5
77
1076
N95
ICD-10 Finland
Menopausal and other perimenopausal disorders
0.7
8.4
257
2729
-44
ICPC
Preventive immunization/medic
1.2
8.4
1145
6993
O68.0
ICD-10 Finland
Labour and delivery complicated by fetal heart rate anomaly
0.7
8.4
209
2298
N02CC04
ATC
rizatriptan; oral
0.8
8.3
640
5955
A06AH03
ATC
naloxegol; oral
1.9
8.3
124
488
K10.3
ICD-10 Finland
Alveolitis of jaws
0.7
8.3
313
3210
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
0.7
8.3
256
2713
M79.7
ICD-10 Finland
Fibromyalgia
0.7
8.3
352
3544
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.2
8.3
1532
9634
8010/2-C50.9
ICD-O-3
Carcinoma in situ, NOS, of breast, NOS
+∞
8.3
9
*
L02BG01
ATC
aminoglutethimide; oral
+∞
8.3
9
*
8501/2-C50.9
ICD-O-3
Comedocarcinoma, noninfiltrating of breast, NOS
+∞
8.3
9
*
8200/3-C50.9
ICD-O-3
Adenoid cystic carcinoma of breast, NOS
+∞
8.3
9
*
8500/3-C50.6
ICD-O-3
Infiltrating duct carcinoma, NOS, of axillary tail of breast
+∞
8.3
9
*
8211/3-C50.8
ICD-O-3
Tubular adenocarcinoma of overlapping lesion of breast
+∞
8.3
9
*
8541/3-C50.1
ICD-O-3
Paget disease and infiltrating duct carcinoma of breast of central portion of breast
+∞
8.3
9
*
T82
ICPC
Obesity
0.7
8.3
292
3025
SPAT1399
SPAT
Acceptance of acknowledgement of paternity of child born outside of marriage before the birth of the child at the maternity clinic. Paternity Act, Section 16.
0.4
8.3
34
620
EBA00
NOMESCO Finland
Extraction of tooth
0.9
8.3
4019
32281
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
1.6
8.2
184
825
O03.9
ICD-10 Finland
Spontaneous abortion, Complete or unspecified, without complication
0.7
8.2
218
2372
N02CC07
ATC
frovatriptan; oral
0.7
8.2
349
3507
SPAT1255
SPAT
Intravenous administration of medicine
1.3
8.2
798
4699
G43.3
ICD-10 Finland
Complicated migraine
0.5
8.2
74
1032
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
0.7
8.1
314
3206
62800
ICD-8 Finland
Sterility, female, Sterilitas primaria
1.5
8.1
250
1213
R01AD12
ATC
fluticasone furoate; nasal
0.9
8.1
4335
34646
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
2.2
8.1
79
264
N02CC05
ATC
almotriptan; oral
0.7
8.0
362
3608
XA402
NOMESCO Finland
ENMG
0.7
8.0
182
2039
O47.1
ICD-10 Finland
False labour at or after 37 completed weeks of gestation
0.6
8.0
141
1667
-31
ICPC
Medical examin/health eval partial
1.2
8.0
926
5559
HAC30
NOMESCO Finland
Excision of supernumerary mammary gland or mamilla
4.5
8.0
28
46
K04.08
ICD-10 Finland
Other specified pulpit
0.8
8.0
465
4474
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
2.4
8.0
67
207
O02.1
ICD-10 Finland
Missed abortion
0.7
7.9
347
3474
O82.10
ICD-10 Finland
Delivery by emergency caesarean section
0.7
7.9
319
3232
LEF13
NOMESCO Finland
Colpoperineoplasty and vaginal hysterectomy
0.7
7.9
377
3729
L57.0
ICD-10 Finland
Actinic keratosis
1.2
7.9
1318
8210
L91.0
ICD-10 Finland
Hypertrophic scar
1.7
7.9
164
720
W85
ICPC
Gestational diabetes
0.5
7.9
58
861
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
0.8
7.9
503
4784
R51.80
ICD-10 Finland
Headache
0.9
7.9
1766
14883
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
2.1
7.9
91
325
O20.0
ICD-10 Finland
Threatened abortion
0.6
7.9
139
1639
N03AX11
ATC
topiramate; oral
0.6
7.8
169
1910
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
0.9
7.8
3543
28574
A10BA02
ATC
metformin; oral
0.9
7.8
3135
25455
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
1.8
7.8
127
516
O34.2
ICD-10 Finland
Maternal care due to uterine scar from previous surgery
0.7
7.8
367
3635
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
3.0
7.8
45
112
MBA00
NOMESCO Finland
Vacuum aspiration from uterus after delivery or abortion
0.6
7.8
153
1764
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
1.5
7.8
261
1290
9822
FHL
Myocutaneous graft
27.0
7.7
11
*
N03AF01
ATC
carbamazepine; oral, rectal
0.8
7.7
447
4305
N06AB05
ATC
paroxetine; oral
1.2
7.7
893
5365
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
0.6
7.7
134
1588
N06AX12
ATC
bupropion; oral
0.8
7.7
441
4250
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
0.9
7.7
7182
55978
EP2AT
NOMESCO Finland
Neck soft tissue cytology with ultrasound guidance
2.9
7.7
48
124
R06.5
ICD-10 Finland
Mouth breathing
0.8
7.7
644
5927
RF210
NOMESCO Finland
NA
1.4
7.7
373
1986
N06AX21
ATC
duloxetine; oral
0.9
7.7
1394
11931
J46
ICD-10 Finland
Status asthmaticus
0.7
7.7
221
2368
Z80.9
ICD-10 Finland
Family history of malignant neoplasm, unspecified
5.1
7.7
24
35
I73.0
ICD-10 Finland
Raynaud syndrome
0.5
7.6
78
1052
SPAT1151
SPAT
Treatment of major wounds
1.8
7.6
133
553
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.1
7.6
3656
24579
MAC96
NOMESCO Finland
Other induction or advancement of labour
0.5
7.6
70
974
N60.2
ICD-10 Finland
Fibroadenosis of breast
1.9
7.6
114
451
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
2.1
7.6
89
320
OAB39
SPAT
NA
0.3
7.6
13
353
R18
ICD-10 Finland
Ascites
1.5
7.6
220
1055
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
0.8
7.6
621
5728
A50
ICPC
General and Unspecified, Medication/prescr/renewal
1.4
7.6
397
2142
OAA67
SPAT
NA
0.8
7.5
619
5712
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.1
7.5
2367
15506
H25.0
ICD-10 Finland
Senile incipient cataract
1.2
7.5
813
4846
L58.0
ICD-10 Finland
Acute radiodermatitis
10.1
7.5
15
11
Z30.5
ICD-10 Finland
Surveillance of (intrauterine) contraceptive device
0.8
7.5
509
4799
6441A
ICD-9 Finland
Early or threatened labour, Other threatened labour
0.6
7.4
113
1380
W11
ICPC
Contraception oral
0.7
7.4
172
1918
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
0.8
7.4
1267
10903
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
0.5
7.4
77
1035
ZZR30
NOMESCO Finland
Flap of muscle
2.6
7.4
52
147
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
0.8
7.4
1267
10898
O24.9
ICD-10 Finland
Diabetes mellitus in pregnancy, unspecified
0.5
7.4
45
711
8503/2-C50.4
ICD-O-3
Noninfiltrating intraductal papillary adenocarcinoma of upper-outer quadrant of breast
+∞
7.4
8
*
8246/3-C50.4
ICD-O-3
Neuroendocrine carcinoma, NOS, of upper-outer quadrant of breast
+∞
7.4
8
*
ZZQ80
NOMESCO Finland
Reanastomosis of blocked anastomosis in a microvascular graft
+∞
7.4
8
*
X51
ICPC
Female Genital, I&d/flush/aspiration
+∞
7.4
8
*
8010/3-C50.4
ICD-O-3
Carcinoma, NOS, of upper-outer quadrant of breast
+∞
7.4
8
*
HA1BM
NOMESCO Finland
Mammary gland MRI examination with 3 Tesla magnet
+∞
7.4
8
*
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
1.4
7.4
312
1621
J35.0
ICD-10 Finland
Chronic tonsillitis
0.7
7.4
340
3376
TJA10
NOMESCO Finland
Laparocentesis
2.7
7.4
50
137
J45.0
ICD-10 Finland
Predominantly allergic asthma
0.8
7.3
880
7807
D01AE16
ATC
amorolfine; topical
1.2
7.3
1809
11649
S70
ICPC
Herpes zoster
1.4
7.3
321
1679
R06AX27
ATC
desloratadine; oral
0.9
7.3
4026
32154
318
Kela drug reimbursment
Teriparatide
0.3
7.3
20
429
Z72.8
ICD-10 Finland
Other problems related to lifestyle
2.6
7.3
53
151
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.9
7.3
1931
16082
G03DB01
ATC
dydrogesterone; oral
0.9
7.3
2345
19289
P99
ICPC
Psychological disorders other
0.6
7.3
143
1647
E10
ICD-10 Finland
Type 1 diabetes mellitus
0.5
7.2
54
800
A07EA06
ATC
budesonide; oral, local oral
0.7
7.2
241
2514
21799
ICD-8 Finland
Benign neoplasm of breast
1.6
7.2
167
756
WC135
NOMESCO Finland
Very demanding cytostatic therapy of local tumor recidive
20.3
7.2
11
*
SDA02
NOMESCO Finland
Parodonthologic therapy
0.9
7.2
4810
38074
XF400
NOMESCO Finland
ECG with 12 standard connections
1.1
7.2
2092
13633
291
Kela drug reimbursment
Tofacitinib
0.1
7.2
*
194
N06BA04
ATC
methylphenidate; oral
0.5
7.2
40
648
G35
ICD-10 Finland
Multiple sclerosis
0.6
7.1
84
1092
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
1.7
7.1
132
560
SDA01
NOMESCO Finland
Simple parodonthologic therapy
0.9
7.1
3437
27643
J01MA02
ATC
ciprofloxacin; systemic
1.1
7.1
6088
42100
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
1.3
7.1
642
3748
QBB99
NOMESCO Finland
Other procedure for wound of skin of trunk
3.0
7.1
40
97
B99
ICD-10 Finland
Other and unspecified infectious diseases
1.6
7.1
199
946
OAA62
SPAT
NA
0.6
7.1
144
1648
G43.8
ICD-10 Finland
Other migraine
0.5
7.1
63
883
GA1CG
NOMESCO Finland
Extensive MRI of chest
3.6
7.0
31
64
WX002
NOMESCO Finland
Sedation and analgesia
1.1
7.0
3106
20781
S21.9
ICD-10 Finland
Open wound of thorax, part unspecified
4.2
7.0
26
46
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
1.4
7.0
345
1842
J01CR50
ATC
combinations of penicillins; systemic
3.3
7.0
34
76
L05
ICPC
Flank/axilla symptom/complaint
1.3
7.0
693
4095
SGA03
NOMESCO Finland
Demanding opening and dilatation of root canal of tooth
0.8
7.0
897
7905
MA2XE
NOMESCO Finland
Other obstetric ultrasound examination
0.7
7.0
319
3166
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
0.5
6.9
44
686
NH3AA
SPAT
NA
0.7
6.9
195
2095
8097/3-C44.5
ICD-O-3
Basal cell carcinoma, nodular of skin of trunk
24.6
6.9
10
*
D82
ICPC
Teeth/gum disease
0.9
6.9
4778
37764
B01AC04
ATC
clopidogrel; oral
0.9
6.9
1249
10692
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.2
6.9
801
4818
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
0.4
6.9
37
608
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
2.2
6.9
70
239
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
0.8
6.8
777
6925
NF1AA
NOMESCO Finland
Hip X-ray examination
1.2
6.8
1258
7916
N60.0
ICD-10 Finland
Solitary cyst of breast
1.8
6.8
111
454
N02CC06
ATC
eletriptan; oral
0.7
6.8
293
2934
K04.00
ICD-10 Finland
Hyperemia of pulp
0.7
6.8
297
2969
2500A
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
0.6
6.8
109
1311
L20.0
ICD-10 Finland
Besnier prurigo
0.8
6.7
484
4531
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.3
6.7
535
3075
TAB00
NOMESCO Finland
Lumbar puncture
0.7
6.7
330
3246
TGA30
NOMESCO Finland
Thoracocentesis
2.2
6.7
64
211
A55
ICPC
General and Unspecified, Local injection/infiltration
1.9
6.7
97
381
61000
ICD-8 Finland
Chronic cystic disease of breast, Fibroadenomatosis mammae
1.7
6.7
128
549
B02
ICD-10 Finland
Zoster [herpes zoster]
1.3
6.7
509
2906
U02
ICPC
Urinary frequency/urgency
1.1
6.7
2336
15403
ND2AA
SPAT
NA
0.7
6.7
189
2026
X06
ICPC
Menstruation excessive
0.4
6.7
33
558
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
0.7
6.7
287
2874
G44.2
ICD-10 Finland
Tension-type headache
0.9
6.6
1791
14905
N76.0
ICD-10 Finland
Acute vaginitis
0.8
6.6
481
4497
M72.2
ICD-10 Finland
Plantar fascial fibromatosis
0.8
6.6
860
7572
H84
ICPC
Presbyacusis
1.4
6.6
365
1988
MAA00
NOMESCO Finland
Amniocentesis
0.6
6.6
128
1478
TQD05
NOMESCO Finland
Puncture of skin of lower limb
4.2
6.6
24
42
QBG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of trunk
3.4
6.6
31
68
DM1QA
SPAT
NA
0.6
6.5
94
1158
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
1.7
6.5
135
595
N92.6
ICD-10 Finland
Irregular menstruation, unspecified
0.8
6.5
629
5696
M70.6
ICD-10 Finland
Trochanteric bursitis
0.9
6.5
2021
16665
QC9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in upper extremities, unspecified
4.3
6.5
23
39
C504, C5041
ICD-10 Finland
NA
+∞
6.5
7
*
8530/3-C50.1
ICD-O-3
Inflammatory carcinoma of central portion of breast
+∞
6.5
7
*
8503/3-C50.2
ICD-O-3
Intraductal papillary adenocarcinoma with invasion of upper-inner quadrant of breast
+∞
6.5
7
*
8520/2-C50.4
ICD-O-3
Lobular carcinoma in situ, NOS, of upper-outer quadrant of breast
+∞
6.5
7
*
L01EF02
ATC
ribociclib; oral
+∞
6.5
7
*
N02CC03
ATC
zolmitriptan; nasal, oral
0.8
6.4
609
5528
ZZA20
NOMESCO Finland
Split skin xenograft
18.4
6.4
10
*
Z30.4
ICD-10 Finland
Surveillance of contraceptive drugs
0.7
6.4
150
1664
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
1.9
6.4
88
339
SFA00
NOMESCO Finland
Small filling
0.9
6.4
1521
12762
L04AD01
ATC
ciclosporin; systemic
0.6
6.4
92
1131
XX3XT
NOMESCO Finland
Other labeling with other radiological guidance
13.5
6.4
11
6
D70.81
ICD-10 Finland
Neutropenia congenital
6.6
6.3
16
18
Z20.8
ICD-10 Finland
Contact with and exposure to other communicable diseases
0.8
6.3
589
5357
O80.8
ICD-10 Finland
Other single spontaneous delivery
0.6
6.3
127
1453
W84
ICPC
Pregnancy high risk
0.5
6.3
56
785
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
0.8
6.3
702
6269
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
0.9
6.3
3622
28891
M53.0
ICD-10 Finland
Cervicocranial syndrome
0.8
6.3
992
8585
X20
ICPC
Nipple symptom/complaint female
2.4
6.3
50
151
H05AA02
ATC
teriparatide; parenteral
0.4
6.3
19
390
Y83.6
ICD-10 Finland
Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.6
6.3
44
125
Z35.4
ICD-10 Finland
Supervision of pregnancy with grand multiparity
0.3
6.3
18
380
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
0.7
6.3
251
2540
A40.1
ICD-10 Finland
Sepsis due to streptococcus, group B
3.3
6.2
30
67
9101
FHL
Bone biopsy
3.2
6.2
31
71
L03
ICPC
Low back symptom/complaint
0.9
6.2
3474
27757
SGC10
NOMESCO Finland
Covering pulpa of tooth
0.8
6.2
739
6554
K04.1
ICD-10 Finland
Necrosis of pulp
0.8
6.2
1030
8876
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
2.1
6.1
68
243
VALMI
NOMESCO Finland
NA
0.9
6.1
3240
25955
L03.9
ICD-10 Finland
Cellulitis, unspecified
1.5
6.1
212
1062
NA7DM
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with 3 Tesla magnet
5.3
6.1
18
25
C79.3
ICD-10 Finland
Secondary malignant neoplasm of brain and cerebral meninges
5.3
6.1
18
25
N92
ICD-10 Finland
Excessive, frequent and irregular menstruation
0.4
6.1
29
499
Z32.0
ICD-10 Finland
Pregnancy, not (yet) confirmed
0.5
6.1
58
794
C79
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified sites
22.1
6.1
9
*
X11
ICPC
Menopausal symptom/complaint
0.6
6.1
115
1333
N92.4
ICD-10 Finland
Excessive bleeding in the premenopausal period
0.8
6.1
524
4805
M77.0
ICD-10 Finland
Medial epicondylitis
0.7
6.1
165
1780
SXA20
NOMESCO Finland
Local application of medicine to mouth
0.8
6.1
470
4361
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
0.8
6.1
585
5300
L04AX07
ATC
dimethyl fumarate; oral
0.1
6.1
*
155
G03FB01
ATC
norgestrel and estrogen; systemic (progestogens and estrogens, sequential prep.)
1.3
6.1
350
1924
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
0.4
6.1
25
452
O02.0
ICD-10 Finland
Blighted ovum and nonhydatidiform mole
0.7
6.1
212
2190
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
0.9
6.0
1227
10413
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
0.5
6.0
35
560
N60.4
ICD-10 Finland
Mammary duct ectasia
2.7
6.0
40
111
XX1XW
NOMESCO Finland
Extensive written report from radiologist
1.5
6.0
226
1150
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023368) Bacteria identified in Blood by Culture
7291
34212
1.77
311.62
3.9
4.0
—
—
—
0
0
(4035726)
7542
10199
7.31
307.65
1.4
1.3
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
17608
74452
3.61
307.65
9.2
5.2
umol/l
9.4
10.4
33.42
17154
69809
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
7354
33467
1.84
307.65
2.1
2.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
12950
51688
2.74
307.65
6.0
2.8
mmol/l
2.4
2.4
91.83
11854
44239
(3002256) Pathology report gross observation
6684
17634
3.40
307.65
1.3
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
739
708
7.74
307.65
1.2
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
5453
1881
26.73
307.65
1.4
1.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
13177
68389
1.86
307.65
5.3
5.3
mmol/l
1.2
1.2
57.45
12192
61311
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
1073
1648
4.87
307.65
1.3
1.4
nmol/l
0.3
0.4
5.64
665
1230
(3013650) Neutrophils [#/volume] in Blood by Automated count
17523
83306
2.89
307.65
12.2
8.5
e9/l
3.5
4.0
175.16
15984
72165
(40758558) Short blood count panel - Blood
9527
36240
2.48
307.65
8.9
6.4
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
2557
140
147.26
307.65
1.0
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
1031
1046
7.38
307.65
1.1
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
13907
65593
2.25
307.65
3.6
3.8
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
4921
851
52.15
307.65
4.0
1.3
u/ml
38.8
32.6
0.93
4759
801
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
21583
114414
4.42
307.65
11.3
6.7
u/l
78.9
78.3
1.15
21051
106686
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
1342
245
41.78
307.65
1.1
1.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
10448
43893
2.26
307.65
2.1
2.3
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
2926
512
46.78
307.65
4.3
1.3
u/ml
48.2
50.1
0.10
2901
498
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
14336
75862
1.90
307.65
6.5
5.9
mmol/l
1.2
1.2
34.96
11808
63912
(40768804) Tissue Pathology biopsy report
13561
64153
2.20
307.65
2.4
2.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
5864
14094
3.64
307.65
3.9
3.7
ug/l
14.1
24.7
2.08
4477
11139
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
1938
3498
4.26
307.65
1.2
1.3
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
3413
12841
2.07
281.41
1.7
2.2
g/l
0.2
0.2
33.86
3283
11868
(3018418) pH of Serum or Plasma
8868
46002
1.62
246.52
4.3
3.7
ph
7.4
7.4
9.44
2116
8012
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
3173
12443
1.97
229.79
3.1
3.7
u/ml
60.8
54.2
0.27
3081
12000
(3024561) Albumin [Mass/volume] in Serum or Plasma
11446
64749
1.52
205.34
3.8
4.4
g/l
35.6
35.7
0.58
10650
59625
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
21274
140252
1.80
177.51
17.2
12.2
ml/min/173m2
80.0
79.2
7.72
19034
114450
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
11839
69489
1.45
160.48
2.2
2.3
nmol/l
82.1
1398.2
0.50
10782
62185
(40758358) Immune stain study
121
20
43.86
155.43
1.0
1.0
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
2843
12120
1.78
154.51
4.1
3.3
mmol/l
1.2
1.2
8.14
2625
10352
(3042936) Bacteria identified in Isolate by Culture
3909
18519
1.62
143.20
1.8
1.9
—
—
—
0
0
(3019225) pH of Specimen
3305
15029
1.68
141.89
4.4
4.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
6492
34708
1.48
137.00
1.3
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
897
2581
2.57
134.51
1.2
1.3
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
22498
153691
1.83
115.50
17.1
15.1
mmol/l
139.7
139.8
0.76
22065
149756
(3023103) Potassium [Moles/volume] in Serum or Plasma
22509
154109
1.80
108.52
17.3
15.2
mmol/l
3.9
3.9
4.55
22044
149879
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
21810
148133
1.65
106.67
16.6
13.4
mg/l
21.5
21.0
1.39
17984
116228
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
631
1712
2.70
106.00
1.2
1.2
u/l
58.9
58.4
0.09
405
1175
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
5461
29462
1.44
104.59
3.0
2.9
mmol/l
2.5
2.5
20.17
4885
25566
(3033658) Prothrombin time (PT) actual/Normal
6576
36676
1.40
104.48
3.3
3.6
%
95.0
95.2
0.28
6428
35605
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
2935
13994
1.58
101.51
3.3
3.3
—
—
—
0
0
(3013512) EKG study
7314
42701
1.34
82.81
3.8
3.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
4092
21741
1.43
82.36
1.8
1.8
—
—
—
0
0
(3044889) 12 lead EKG panel
16103
105099
1.32
79.63
3.7
3.6
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
22707
157398
1.69
76.59
21.4
15.2
umol/l
69.0
70.0
10.33
22702
157329
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
22769
157978
1.71
75.89
14.9
10.1
u/l
24.3
23.9
1.76
22290
152085
(3032080) INR in Blood by Coagulation assay
9107
55911
1.28
67.27
7.3
7.6
inr
1.2
1.2
0.23
2764
15850
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
735
2617
2.06
67.00
1.4
1.3
u/l
41.2
37.6
1.71
689
2040
(3013826) Glucose [Moles/volume] in Serum or Plasma
13059
83897
1.27
65.89
3.9
4.2
mmol/l
6.5
6.6
8.00
12409
78363
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
322
801
2.93
63.43
1.2
1.1
u/l
74.0
83.8
1.49
282
618
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
323
805
2.92
63.41
1.2
1.1
u/l
17.3
25.4
2.12
277
600
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
359
1017
2.57
55.51
1.6
1.5
u/l
5.8
6.3
0.21
181
483
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
343
976
2.56
52.58
1.2
1.2
u/l
16.9
24.4
1.79
302
834
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
346
998
2.52
51.61
1.2
1.2
u/l
68.2
86.1
3.63
316
875
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
804
9693
0.58
47.06
1.6
1.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
1151
12663
0.64
45.69
1.3
1.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
8036
50296
1.23
44.28
4.8
6.0
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
313
936
2.43
43.36
1.5
1.6
ug/l
1.6
5.0
2.57
180
664
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
698
8499
0.58
42.32
1.6
1.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
831
3610
1.68
40.52
1.6
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
1182
5605
1.55
40.32
1.9
1.9
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
10147
65431
1.20
40.04
10.7
9.1
e9/l
0.0
0.0
2.72
8271
53531
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
2703
14983
1.34
39.27
1.7
1.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
18938
142743
0.80
39.13
3.8
4.0
mmol/l
1.3
1.3
0.03
16747
130621
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
2704
15001
1.34
39.05
1.7
1.7
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
689
2875
1.75
38.83
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
689
2875
1.75
38.83
1.2
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
686
2876
1.74
38.04
1.4
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
557
6986
0.57
37.65
1.3
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
1082
5116
1.55
37.36
1.7
1.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
3400
30222
0.78
36.12
1.2
1.3
u/ml
10.1
12.7
1.44
1246
11800
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
7593
47995
1.21
35.76
3.9
3.0
u/l
35.3
31.8
1.55
7220
45371
(3012095) Magnesium [Moles/volume] in Serum or Plasma
3928
23188
1.27
35.23
2.9
3.0
mmol/l
0.8
0.8
0.62
3635
21377
(40768806) Pleura Pathology biopsy report
312
1024
2.21
35.11
1.5
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
3582
31550
0.79
35.10
1.3
1.3
iu/ml
33.6
37.4
0.67
1117
10387
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
654
2779
1.72
34.60
1.4
1.6
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
375
1333
2.05
34.47
1.4
1.4
g/l
34.9
32.5
3.21
344
1199
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
521
2076
1.83
34.27
1.5
1.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
1543
7992
1.42
33.78
1.6
1.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
19782
147822
0.81
31.62
4.3
4.4
mmol/l
1.6
1.6
14.63
17698
136318
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
477
5953
0.57
31.60
1.4
1.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
19950
148924
0.81
31.36
4.3
4.5
mmol/l
4.9
4.9
0.65
17944
137948
(3051651) Icteric interference index of Serum or Plasma
241
744
2.35
31.30
2.4
3.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
2878
16601
1.28
30.78
1.6
1.7
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
2589
23378
0.77
30.60
1.3
1.4
titre
516.1
596.5
1.61
591
5282
(3001122) Ferritin [Mass/volume] in Serum or Plasma
8335
66831
0.85
30.12
2.5
2.8
ug/l
134.6
101.8
15.91
7547
61868
(3002030) Lymphocytes/100 leukocytes in Blood
10846
71457
1.17
29.92
5.1
6.2
%
27.1
28.9
51.51
10042
66278
(3019069) Monocytes/100 leukocytes in Blood
10608
69780
1.17
29.79
5.2
6.4
%
8.7
8.3
17.73
9889
65094
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
11913
92770
0.85
29.57
2.6
2.8
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
915
4395
1.52
29.39
2.7
3.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
17837
122506
1.19
29.09
21.7
16.1
%
13.8
13.7
6.90
17621
119782
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
20404
151732
0.81
28.55
4.9
5.0
mmol/l
2.9
2.9
3.58
18253
139895
(46235355) HIV 1 and 2 tests - Meaningful Use set
1925
17914
0.76
28.44
1.5
1.6
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
495
2071
1.74
27.74
2.3
3.2
%
2.3
1.3
5.73
383
1628
(3006504) Eosinophils/100 leukocytes in Blood
10524
69457
1.17
27.46
5.0
6.1
%
2.7
2.8
8.73
9755
64431
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
79
135
4.23
27.27
1.4
1.2
nmol/l
0.2
0.4
0.84
51
87
(3031040) Bacteria [#/volume] in Urine by Automated count
14830
100550
1.17
26.94
4.8
4.8
e6/l
2634.2
2271.5
0.20
166
1195
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
363
4673
0.55
26.92
1.3
1.5
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
281
1008
2.02
25.34
1.4
1.4
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
10198
67410
1.16
25.26
5.0
6.1
%
0.7
0.7
0.08
9457
62509
(3023323) Follitropin [Units/volume] in Serum or Plasma
1586
8674
1.34
24.74
1.4
1.3
iu/l
42.6
36.9
8.32
1364
7644
(3019150) Specific gravity of Urine by Refractometry
3946
33280
0.83
24.15
4.3
4.6
kg/l
1.0
1.0
0.80
629
5118
(3008898) HLA-B27 [Presence]
452
5336
0.60
24.10
1.0
1.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
6014
38284
1.18
23.84
2.7
3.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
6128
39072
1.18
23.82
2.8
3.0
e6/l
0.5
0.4
0.96
4468
29001
(3023199) Leukocytes [#/volume] in Pleural fluid
320
1232
1.89
23.59
1.4
1.4
e6/l
3910.1
2861.0
0.22
234
887
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
3610
21986
1.22
23.28
2.5
2.7
e6/l
4.0
4.9
3.24
1806
11434
(3018010) Neutrophils/100 leukocytes in Blood
10602
70537
1.15
23.28
4.9
6.0
%
57.3
56.7
5.34
9842
65672
(3028308) Erythrocytes [#/volume] in Pleural fluid
292
1105
1.92
22.69
1.4
1.4
e6/l
36295.3
42839.7
0.21
161
629
(3002582) Erythrocytes [#/volume] in Urine
6553
42163
1.17
22.46
2.9
3.1
e6/l
98.0
63.9
0.83
4819
31617
(3026008) Bacteria identified in Urine by Culture
8053
52684
1.15
21.97
3.3
3.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
5557
35341
1.17
21.95
1.4
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
712
7451
0.68
21.62
1.5
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
6603
52942
0.86
21.42
2.8
2.8
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
163
2489
0.47
20.80
1.3
1.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
21869
154179
1.25
20.69
15.7
12.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
192
652
2.13
20.11
1.6
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
192
652
2.13
20.11
1.6
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
192
652
2.13
20.11
1.6
1.7
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
2255
19778
0.80
19.97
1.9
2.1
ug/g
126.9
122.9
0.12
1679
15272
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
175
574
2.21
19.96
2.0
3.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
192
654
2.13
19.96
1.6
1.7
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
301
1207
1.81
19.62
1.5
1.6
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
403
4622
0.62
19.05
1.5
1.6
iu/ml
3.5
7.6
0.32
95
974
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1815
16220
0.79
18.97
1.4
1.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
917
4802
1.39
18.80
1.9
1.9
ug/l
1.7
2.5
1.07
804
4161
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
234
885
1.92
18.32
1.3
1.3
u/l
365.9
383.4
0.07
224
833
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
316
1314
1.74
18.27
1.5
1.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
18633
138715
0.86
18.18
5.4
5.6
mmol/mol
39.4
39.4
0.04
16796
128200
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
315
1311
1.74
18.16
1.4
1.6
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
2159
12770
1.24
18.16
2.6
3.3
ng/l
75.5
82.9
4.68
1841
10778
(3021387) Prolactin [Units/volume] in Serum or Plasma
283
3490
0.58
18.02
1.7
1.7
mu/l
326.3
337.3
0.14
263
3123
(3026782) Osmolality of Urine
4322
27304
1.17
18.01
2.5
2.7
mosm/kgh2o
498.8
502.6
0.50
3642
23014
(3003338) MCHC [Mass/volume]
16669
125021
0.88
18.00
23.3
17.4
g/l
329.9
330.4
14.63
16575
124093
(3015171) Extractable nuclear Ab [Units/volume] in Serum
743
7450
0.71
17.72
1.2
1.3
u/ml
1.7
0.9
0.59
63
698
(3045788) Cell count panel - Pleural fluid
245
952
1.87
17.70
1.5
1.5
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
1105
10416
0.75
17.57
1.3
1.3
u/ml
184.9
191.4
0.09
1000
9631
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
2020
11909
1.24
17.48
3.6
2.5
ml/min/173m2
66.7
64.8
1.76
841
4847
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
269
1083
1.80
17.37
1.5
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
269
1083
1.80
17.37
1.5
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
269
1083
1.80
17.37
1.5
1.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
366
1607
1.65
17.36
1.4
1.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
4632
37647
0.86
17.22
2.2
2.3
umol/l
5568.0
4251.5
1.19
3872
32367
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
4428
36106
0.86
17.19
1.2
1.3
u/ml
1.6
1.5
0.09
1008
9810
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
465
2177
1.55
16.93
1.3
1.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
153
512
2.16
16.72
1.7
1.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
153
512
2.16
16.72
1.7
1.8
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
154
522
2.14
16.31
1.7
1.8
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
7708
51042
1.13
16.16
3.4
3.6
e6/l
109.8
115.4
0.24
5216
34773
(3051611) Lipemic interference index of Serum or Plasma
351
1560
1.63
15.92
2.6
3.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
390
4268
0.65
14.93
1.3
1.3
miu/ml
238.5
221.0
0.41
179
2058
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
7573
50287
1.13
14.84
2.9
3.2
—
0.1
—
0
9
(3001019) Free T4 and TSH panel - Serum or Plasma
970
9096
0.76
14.83
1.7
1.8
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
1320
7550
1.28
14.77
4.7
6.3
mmol/l
25.2
25.1
0.61
1305
7480
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
6307
41428
1.13
14.74
2.7
2.8
ng/l
1126.6
1203.4
0.81
5342
35038
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
232
949
1.77
14.31
1.4
1.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
523
2606
1.46
14.21
1.3
1.4
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
232
954
1.76
14.07
1.3
1.3
mmol/l
6.4
6.5
0.34
217
892
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
55
119
3.34
13.96
1.5
3.0
mg/l
1.1
1.5
0.35
26
88
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
1855
11109
1.22
13.78
1.5
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
7431
57915
0.89
13.72
4.1
4.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
5531
43863
0.88
13.71
3.6
3.8
mg/mmol
5.8
7.4
1.68
2858
24923
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
215
875
1.78
13.52
1.4
1.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
1601
13991
0.81
13.43
1.5
1.6
%
1.4
1.4
0.60
1358
12255
(3013139) Helicobacter pylori Ag [Presence] in Stool
1370
12155
0.80
13.27
1.2
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
5511
43591
0.89
12.94
2.8
3.0
mmol/l
6.2
6.4
2.72
4410
36481
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
17055
126990
0.89
12.93
4.5
4.6
pmol/l
14.9
14.8
10.61
15263
116640
(3017181) Myelocytes/100 leukocytes in Blood
2023
12319
1.20
12.64
3.1
4.2
%
1.8
0.8
20.52
777
3055
(3012516) Albumin [Mass/volume] in Urine
5272
41756
0.89
12.59
2.9
3.1
mg/l
464.7
501.2
0.18
2734
23469
(3007461) Platelets [#/volume] in Blood
22980
163731
1.26
12.58
26.6
19.8
e9/l
258.9
264.2
31.75
22549
159286
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
173
678
1.85
12.34
1.2
1.3
u/l
11.3
11.6
0.09
161
611
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
950
5341
1.29
12.20
2.7
3.2
u/ml
1801.1
2128.4
0.09
794
4472
(4034850)
539
5342
0.72
12.04
11.6
9.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
556
5482
0.73
12.03
1.7
1.9
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
77
221
2.52
12.00
1.2
1.3
ug/l
636.9
162.4
0.87
54
132
(3017143) Hepatitis C virus Ab [Presence] in Serum
1619
13973
0.82
11.94
1.4
1.5
—
—
—
0
0
(3035941) MCH [Entitic mass]
22981
163820
1.25
11.73
26.4
19.7
pg
30.3
30.2
57.14
22756
161360
(3024731) MCV [Entitic volume]
22981
163830
1.25
11.63
26.5
19.7
fl
91.9
91.1
141.94
22756
161369
(3026361) Erythrocytes [#/volume] in Blood
22981
163844
1.25
11.49
26.6
19.8
e12/l
4.3
4.4
205.27
22516
158897
(3010813) Leukocytes [#/volume] in Blood
22982
163857
1.25
11.44
26.6
19.8
e9/l
6.2
6.6
20.29
22518
158906
(3005719) IgG [Mass/volume] in Serum or Plasma
1291
11338
0.81
11.34
2.7
2.8
g/l
10.1
10.4
1.01
1163
10378
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
98
1435
0.49
11.32
1.3
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
1454
12612
0.82
11.29
3.4
3.7
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
22981
163880
1.24
11.12
26.7
19.9
g/l
129.8
132.2
172.51
22761
161465
(3016879) Cocaine [Presence] in Urine
227
2614
0.62
11.11
1.9
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
252
2832
0.64
11.05
1.9
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
639
3463
1.34
10.72
1.1
1.2
—
—
—
0
0
(1002224) Polysomnography panel
622
5918
0.75
10.62
1.1
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
94
1361
0.50
10.53
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
94
1360
0.50
10.51
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
94
1356
0.50
10.42
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
94
1355
0.50
10.40
1.3
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
3763
24387
1.13
10.39
2.4
2.6
e6/l
2.2
1.4
0.52
1954
13698
(3028300) Cannabinoids [Presence] in Urine
263
2884
0.65
10.31
1.8
1.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
79
1204
0.47
10.30
1.2
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
120
1597
0.54
10.28
1.4
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
443
4413
0.72
10.28
1.7
1.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
184
2184
0.60
10.28
2.0
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
263
2873
0.66
10.13
1.8
1.6
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
37
765
0.35
10.12
1.2
1.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
230
2583
0.64
10.10
1.1
1.1
u/ml
1.5
1.0
0.33
81
880
(3000764) Benzodiazepines [Presence] in Urine
262
2861
0.66
10.07
1.8
1.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
3804
30369
0.89
10.01
1.4
1.4
g/l
2.2
2.3
0.69
1902
17976
(40761536) Microorganisms panel - Urine sediment
1968
12202
1.18
9.99
4.3
4.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
203
2335
0.62
9.94
1.1
1.1
u/ml
4.0
3.0
0.36
79
1036
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
524
5048
0.74
9.79
1.4
1.7
g/l
0.2
0.2
1.05
489
4765
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
2952
18904
1.14
9.73
4.5
4.6
%
33.8
33.3
1.51
1829
12761
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
541
5182
0.75
9.72
1.4
1.7
g/l
1.2
1.2
0.11
506
4914
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
230
2556
0.65
9.64
2.0
1.8
nmol/l
0.9
0.8
0.30
181
2131
(3035880) pH of Pleural fluid
137
543
1.82
9.55
1.3
1.2
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
854
7695
0.79
9.52
1.1
1.1
titre
432.1
185.9
0.76
17
168
(3010726) Horse dander IgE Ab [Units/volume] in Serum
178
2088
0.61
9.50
1.1
1.1
u/ml
0.9
1.4
0.60
38
434
(3008401) Mugwort IgE Ab [Units/volume] in Serum
194
2230
0.62
9.49
1.1
1.1
u/ml
1.4
0.8
0.42
70
816
(3014133) Dog dander IgE Ab [Units/volume] in Serum
153
1857
0.59
9.40
1.0
1.1
u/ml
4.1
3.4
0.24
48
628
(3024869) Neuronal Ab [Presence] in Serum
70
217
2.33
9.37
1.1
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
62
991
0.45
9.27
1.5
1.7
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
11256
77505
1.09
9.27
5.0
6.1
e9/l
0.2
0.2
26.64
9620
68223
(3013727) Leukocytes other/100 leukocytes in Blood
107
395
1.96
9.26
2.2
3.7
%
49.0
53.0
0.81
101
383
(3008757) Leukocyte morphology finding [Identifier] in Blood
294
1431
1.49
9.18
2.5
3.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
19615
144295
0.90
9.17
5.3
5.5
mu/l
2.0
2.0
0.06
17689
133361
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
257
1219
1.53
9.07
1.7
1.8
ug/l
18.1
25.4
2.07
250
1192
(3023430) Cat dander IgE Ab [Units/volume] in Serum
142
1736
0.59
9.00
1.0
1.1
u/ml
2.7
3.3
0.23
49
625
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
1429
12142
0.84
8.86
1.2
1.2
iu/ml
162.1
148.4
0.62
554
4778
(3021440) Promyelocytes/100 leukocytes in Blood
1887
11781
1.17
8.79
3.2
4.2
%
0.3
0.1
8.67
709
2820
(3017354) Segmented neutrophils/100 leukocytes in Blood
273
1322
1.50
8.76
2.5
3.2
%
57.4
58.3
0.22
167
880
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
1928
15963
0.86
8.66
1.6
1.6
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
113
1452
0.56
8.65
1.4
1.5
—
2.1
—
0
12
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
119
1507
0.57
8.64
1.0
1.0
u/ml
0.4
0.3
0.09
23
283
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
499
4750
0.75
8.62
1.3
1.3
u/ml
4.6
5.9
0.22
46
524
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
318
1594
1.45
8.58
1.4
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
166
1929
0.62
8.57
2.1
2.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
508
4817
0.76
8.54
1.3
1.3
u/ml
7.6
7.0
0.08
78
837
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
563
5261
0.77
8.49
1.2
1.3
u/ml
21.6
41.0
1.08
27
347
(3014111) Lactate [Moles/volume] in Serum or Plasma
1812
11314
1.17
8.43
5.0
6.1
mmol/l
1.3
1.3
0.42
1752
10938
(3002179) Metamyelocytes/100 leukocytes in Blood
1800
11235
1.17
8.41
3.1
4.0
%
1.2
0.6
12.43
537
2215
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
77
261
2.13
8.40
1.1
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
1185
7137
1.21
8.36
1.2
1.2
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
722
4124
1.27
8.31
1.7
2.0
%
95.9
95.3
0.27
653
3790
(3010421) pH of Blood
609
3417
1.29
8.08
3.1
3.4
ph
7.4
7.4
1.46
506
2823
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
95
1250
0.55
7.95
1.5
1.7
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
11091
76623
1.08
7.91
4.9
5.9
e9/l
1.7
1.9
44.67
9528
67636
(44790048)
267
1316
1.47
7.91
1.2
1.5
—
—
—
0
0
(44790049)
267
1316
1.47
7.91
1.2
1.5
—
—
—
0
0
(44806118)
267
1316
1.47
7.91
1.2
1.5
—
—
—
0
0
(44790047)
267
1316
1.47
7.91
1.2
1.5
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
390
2058
1.37
7.89
1.8
1.8
mmol/l
1.7
1.7
0.80
380
2011
(3043238) Trisomy 21 risk [Likelihood] in Fetus
88
1181
0.54
7.88
1.3
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
952
8280
0.82
7.64
1.0
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
85
1139
0.54
7.59
1.3
1.4
—
—
—
0
0
(3012501) Base excess in Blood by calculation
521
2889
1.31
7.58
3.3
3.5
mmol/l
2.6
2.7
0.47
387
2055
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
960
8336
0.82
7.58
1.5
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
725
4192
1.26
7.57
2.2
2.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
413
2215
1.35
7.56
1.3
1.4
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
521
2890
1.31
7.56
3.3
3.5
kpa
5.0
5.1
0.22
505
2824
(3005033) Fetal Nuchal fold Thickness US
85
1134
0.54
7.49
1.3
1.4
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
234
2453
0.69
7.43
1.3
1.5
g/l
0.6
0.6
0.36
168
1852
(3000919) Neutrophils/100 leukocytes in Pleural fluid
76
272
2.02
7.26
1.4
1.3
%
11.8
21.0
3.28
68
251
(3035350) Ketones [Presence] in Urine by Test strip
9996
75327
0.93
7.24
3.8
4.0
estimate
0.0
0.0
0.15
1953
13305
(3028026) IgM [Mass/volume] in Serum or Plasma
1030
8845
0.83
7.23
1.8
1.8
g/l
1.3
1.3
0.49
918
8042
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
92
353
1.88
7.22
1.4
1.3
%
68.1
61.9
1.07
79
294
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
31
588
0.38
7.18
3.7
3.5
u/ml
39.4
1718.7
—
5
49
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
1429
11931
0.86
7.17
1.3
1.3
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
422
4000
0.76
7.15
1.2
1.3
u/ml
29.2
46.5
1.98
41
466
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
162
733
1.60
7.13
1.5
1.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
2793
18169
1.12
7.11
22.6
22.0
inr
1.3
1.3
0.07
391
2522
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
270
1365
1.43
7.06
1.2
1.2
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
521
2919
1.29
7.05
3.3
3.6
kpa
8.5
8.6
0.26
505
2853
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
1491
12391
0.86
7.04
1.8
1.7
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
147
652
1.63
7.02
1.5
1.5
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
526
2953
1.29
7.01
2.9
3.2
u/ml
205.6
823.3
2.32
476
2661
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
149
665
1.62
6.95
1.5
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
20037
146859
0.91
6.94
4.6
4.6
mmol/l
5.9
5.8
1.19
17881
134590
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
1297
8013
1.18
6.92
1.4
1.5
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
645
3722
1.26
6.89
2.0
2.5
g/l
3.6
3.6
0.40
623
3528
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
53
168
2.28
6.86
1.0
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
294
2918
0.72
6.82
2.1
2.3
ug/min
75.2
64.1
0.22
149
1606
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
731
6446
0.81
6.77
1.6
1.6
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
79
295
1.93
6.74
1.4
1.3
%
2.0
2.8
0.50
66
251
(3025468) Yersinia sp identified in Specimen by Organism specific culture
374
2015
1.34
6.71
1.4
1.4
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
2267
14618
1.13
6.67
3.8
4.0
u/l
260.1
243.9
2.97
2121
13722
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
157
718
1.58
6.65
1.5
1.4
u/l
11.6
12.7
1.43
150
692
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
664
3862
1.25
6.64
2.2
2.3
%
195.5
187.7
1.41
635
3614
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
170
1848
0.66
6.57
1.1
1.1
iu/ml
45.3
6934.5
0.57
48
356
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
1075
6567
1.19
6.57
6.8
8.2
mmol/l
24.7
24.6
0.46
1006
6124
(3028707) Methadone [Presence] in Urine by Screen method
110
1317
0.60
6.56
2.6
1.9
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
10821
75040
1.07
6.45
4.8
5.9
e9/l
0.0
0.0
6.74
9129
65005
(3014891) Appearance of Pleural fluid
46
141
2.36
6.44
1.4
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
372
2018
1.33
6.40
1.4
1.4
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
541
4895
0.79
6.38
1.5
1.6
titre
118.5
288.9
4.38
23
240
(3014148) Varicella zoster virus Ab [Titer] in Serum
141
1581
0.64
6.34
1.1
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
375
2040
1.33
6.33
1.4
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
372
2022
1.33
6.32
1.4
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
374
2035
1.33
6.31
1.4
1.4
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
100
1213
0.59
6.30
1.2
1.2
titre
159.3
179.6
0.08
14
207
(3001604) Monocytes [#/volume] in Blood
10765
74686
1.07
6.27
4.8
5.9
e9/l
0.5
0.6
2.32
9094
64743
(4010399)
1401
11581
0.86
6.17
1.4
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
347
1874
1.34
6.17
1.4
1.4
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
932
5658
1.20
6.13
1.4
1.4
pmol/l
146.7
154.0
0.19
909
5527
(3004716) Salmonella sp identified in Stool by Organism specific culture
945
8043
0.84
6.04
1.4
1.4
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
420
3889
0.78
6.03
1.2
1.3
u/ml
1.1
6.3
3.85
26
312
(40767503) Oxygen content in Capillary blood by calculation
485
2755
1.28
5.97
2.3
2.5
%
16.1
16.0
0.06
218
1396
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
107
1258
0.61
5.96
1.2
1.4
—
6062.2
—
0
9
(40768441) Liver Pathology biopsy report
215
1079
1.44
5.93
1.1
1.3
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
314
1682
1.35
5.91
1.7
1.7
%
90.2
89.9
0.60
309
1653
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
46
147
2.26
5.90
1.4
1.3
%
13.3
13.0
0.02
27
74
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
115
1322
0.63
5.83
1.2
1.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
4397
29549
1.09
5.82
2.3
2.5
e6/l
7.9
7.5
0.86
3800
25600
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
326
1764
1.34
5.75
1.4
1.4
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
3097
20490
1.10
5.74
1.9
2.0
s
29.3
29.4
0.42
3001
19840
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
156
1675
0.67
5.73
1.1
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
49
163
2.17
5.73
1.0
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
10131
75903
0.94
5.69
5.1
5.4
estimate
0.0
0.0
3.97
1947
13424
(3020874) Milk IgE Ab [Units/volume] in Serum
68
887
0.55
5.67
1.0
1.0
u/ml
0.4
1.0
0.90
23
241
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
6065
46250
0.93
5.65
1.9
2.1
u/l
159.5
161.4
0.06
5612
43107
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
1218
7624
1.16
5.57
1.3
1.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
27
482
0.40
5.54
1.3
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
377
2095
1.30
5.53
1.4
1.4
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
18
386
0.34
5.53
1.7
2.3
au/ml
167.5
177.6
—
6
47
(3009261) Glucose [Presence] in Urine by Test strip
10243
76656
0.94
5.48
3.8
4.0
estimate
0.0
0.0
0.59
1973
13481
(3036489) Thrombin time
850
5186
1.19
5.34
1.7
1.9
s
21.7
21.4
0.49
742
4451
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
509
4539
0.80
5.34
1.1
1.1
u/ml
3.8
7.0
1.54
63
517
(40763480) Human metapneumovirus Ag [Presence] in Specimen
23
54
3.07
5.32
1.0
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
1072
8933
0.86
5.31
1.2
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
626
5462
0.82
5.30
1.6
1.7
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
66
848
0.56
5.25
1.1
1.0
u/ml
0.6
1.6
0.80
20
185
(3038177) Helicobacter pylori Ab [Presence] in Serum
282
2699
0.75
5.25
1.3
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
4797
36816
0.93
5.23
3.5
4.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
29
79
2.65
5.21
1.1
1.0
—
—
—
0
0
(3015736) pH of Urine
7776
58649
0.94
5.20
3.5
3.8
ph
5.8
5.8
—
9
18
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
257
2489
0.74
5.20
1.1
1.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
31
507
0.44
5.14
1.7
1.7
ug/l
9.6
8.8
0.63
31
507
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
192
1941
0.71
5.11
1.2
1.2
u/l
30.3
33.4
0.23
160
1687
(3000991) Gas panel - Venous blood
1653
10634
1.13
5.09
5.9
7.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
225
1176
1.38
5.01
2.3
2.9
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
1789
11579
1.12
4.99
2.5
2.6
g/l
66.1
66.5
1.19
1593
10358
(3027135) IgG subclass 1 [Mass/volume] in Serum
155
1615
0.69
4.93
1.2
1.4
g/l
6.6
6.7
0.01
99
1152
(3024139) IgG subclass 3 [Mass/volume] in Serum
155
1613
0.69
4.90
1.2
1.4
g/l
0.4
0.4
0.11
101
1151
(3028192) IgG subclass 2 [Mass/volume] in Serum
155
1613
0.69
4.90
1.2
1.4
g/l
2.7
2.8
0.28
100
1147
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
150
1566
0.69
4.83
1.0
1.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
4326
33232
0.93
4.79
1.6
1.7
pmol/l
42945434.2
37301032.4
0.22
3416
27391
(3009542) Hematocrit [Volume Fraction] of Blood
18793
133414
1.07
4.70
18.8
14.5
%
38.5
38.9
10.43
13242
95271
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
349
3197
0.78
4.69
1.4
1.4
e6/l
822.5
1926.8
1.67
259
2619
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
98
1106
0.64
4.67
1.2
1.3
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
349
3193
0.79
4.65
1.4
1.4
e6/l
17.9
39.5
1.71
237
2493
(4062490)
157
1613
0.70
4.64
1.2
1.4
—
—
—
0
0
(4281824)
431
2495
1.25
4.63
1.1
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
162
1651
0.71
4.58
1.8
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
5302
40365
0.93
4.57
4.2
4.5
estimate
0.0
0.0
4.03
1940
13414
(3009445) Proteinase 3 Ab [Units/volume] in Serum
734
6221
0.85
4.55
1.3
1.5
u/ml
22.1
15.2
0.32
13
146
(3034770) Mitochondria Ab [Titer] in Serum
505
4424
0.82
4.52
1.2
1.2
titre
511.5
976.5
2.09
20
190
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
98
1097
0.64
4.51
1.2
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
146
721
1.46
4.49
1.3
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
146
721
1.46
4.49
1.3
1.4
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
18
346
0.37
4.46
4.7
5.1
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
308
2840
0.78
4.40
1.2
1.3
titre
91.4
113.0
—
7
57
(3025159) Blasts/100 leukocytes in Blood
1724
11221
1.12
4.39
3.2
4.2
%
0.6
0.2
0.76
591
2434
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
285
1579
1.31
4.38
1.1
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
370
3335
0.80
4.36
1.1
1.2
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
195
1910
0.73
4.33
1.2
1.6
iu/ml
26.4
32.7
—
5
86
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
197
1924
0.74
4.30
1.2
1.2
mmol/l
7.4
7.4
0.03
156
1417
(3003396) Base excess in Arterial blood by calculation
2261
14942
1.10
4.30
5.5
6.3
mmol/l
1.2
1.3
0.54
1871
11922
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
1390
11214
0.89
4.30
2.4
2.4
au/ml
28.3
26.5
0.18
79
651
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
3326
25708
0.92
4.28
1.4
1.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
5052
34509
1.07
4.27
1.6
1.7
mg/l
1.2
1.1
1.65
3889
26480
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
140
1443
0.70
4.25
1.7
1.5
%
35.3
34.1
0.13
82
840
(3042631) Mycobacterium sp identified in Specimen
308
1733
1.29
4.23
2.5
2.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
655
3995
1.19
4.22
2.4
2.9
u/ml
0.4
0.4
0.62
388
2311
(3039162) Centromere protein B Ab [Units/volume] in Serum
256
2401
0.77
4.20
1.2
1.3
u/ml
81.6
57.5
0.54
15
183
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
103
1121
0.66
4.18
1.1
1.2
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
43
580
0.53
4.14
2.3
3.0
umol/l
26.6
28.2
0.40
29
445
(3014576) Chloride [Moles/volume] in Serum or Plasma
2494
16591
1.09
4.12
5.4
6.3
mmol/l
104.2
104.2
0.27
2444
16244
(3034274) Bile acid [Moles/volume] in Serum --fasting
110
1177
0.67
4.11
1.4
1.7
umol/l
6.6
7.6
0.20
74
843
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
2138
14125
1.10
4.10
2.1
2.4
u/l
44.3
38.7
0.56
1819
11949
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
2258
14958
1.10
4.09
5.5
6.3
kpa
5.2
5.1
1.10
2156
14273
(3027801) Oxygen [Partial pressure] in Arterial blood
2257
14952
1.10
4.08
5.5
6.3
kpa
13.6
12.6
8.74
2156
14259
(3015076) Soybean IgE Ab [Units/volume] in Serum
60
732
0.59
4.04
1.1
1.0
u/ml
0.1
0.2
—
6
90
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
62
750
0.60
4.03
1.0
1.1
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
343
1975
1.26
3.93
2.1
2.0
mg/l
27.6
25.3
0.30
99
519
(3037692) Legionella sp identified in Specimen by Organism specific culture
96
449
1.54
3.88
1.0
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
234
2192
0.77
3.84
1.1
1.2
u/ml
279.3
293.0
0.28
144
1403
(44786800) Granulocytes/100 leukocytes in Body fluid
36
127
2.05
3.76
1.3
1.3
%
20.8
23.7
0.20
29
102
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
83
919
0.65
3.71
2.6
2.4
e9/l
0.2
0.2
0.12
72
800
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
252
1409
1.29
3.69
1.1
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
21
346
0.44
3.67
1.2
1.3
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
511
4377
0.84
3.67
1.2
1.2
titre
145.1
154.2
0.07
43
360
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
48
602
0.57
3.63
1.1
1.1
miu/ml
1243.3
1586.6
1.54
48
602
(3037467) Urinalysis macro (dipstick) panel - Urine
14710
103956
1.05
3.63
4.4
4.7
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
20
332
0.43
3.58
1.2
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
113
1168
0.70
3.56
2.3
2.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
123
1252
0.71
3.55
1.1
1.2
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
202
1906
0.76
3.54
4.8
5.2
umol/l
364.6
376.4
0.57
174
1659
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
128
1293
0.71
3.54
1.3
1.3
u/ml
2.7
1.0
0.44
47
589
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
76
847
0.65
3.53
1.1
1.1
u/ml
2.3
6.9
—
7
123
(4027681)
75
838
0.64
3.53
1.4
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
255
2333
0.79
3.51
1.1
1.2
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
106
1104
0.69
3.50
1.2
1.2
mg/l
40.3
40.4
0.00
94
927
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
180
968
1.34
3.49
1.3
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
407
3540
0.83
3.48
1.2
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
5274
39847
0.94
3.47
3.7
3.6
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
75
342
1.58
3.43
1.1
1.2
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
70
787
0.64
3.40
1.0
1.1
u/l
1.1
1.1
0.01
42
359
(3000492) Spirometry study
1764
13868
0.91
3.39
1.4
1.5
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
8
177
0.33
3.38
1.1
1.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
4854
36735
0.94
3.37
2.2
2.3
mg/l
3.0
3.0
0.13
4053
31472
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
97
1017
0.69
3.34
1.1
1.1
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
40
513
0.56
3.32
1.4
2.0
%
12.5
9.5
0.63
34
474
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
687
4298
1.16
3.32
1.2
1.3
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
50
604
0.60
3.31
8.7
10.9
nmol/l
717.3
2511.6
0.56
50
579
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
268
2419
0.80
3.30
1.2
1.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
73
334
1.58
3.30
1.1
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
38
493
0.56
3.29
1.3
1.2
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
43
539
0.57
3.29
23.4
28.0
ug/l
110.3
112.8
0.10
36
450
(3004616) Nuclear Ab [Presence] in Serum
241
2200
0.79
3.28
1.3
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
239
2183
0.79
3.27
1.2
1.4
u/ml
109.8
118.2
0.84
53
536
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
1280
10199
0.90
3.24
1.2
1.3
au/ml
64.0
47.0
1.29
58
442
(3027456) Digoxin [Moles/volume] in Serum or Plasma
481
2931
1.19
3.23
3.2
3.3
nmol/l
0.8
0.8
0.78
373
2325
(3022475) Manganese [Moles/volume] in Blood
31
110
2.03
3.23
1.3
1.2
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
40
506
0.57
3.18
1.4
1.9
%
27.4
28.6
0.20
35
479
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
104
1065
0.70
3.16
1.2
1.1
mg/l
294.4
254.5
0.46
94
933
(3000570) Elastase.pancreatic [Mass/mass] in Stool
588
4912
0.86
3.16
1.3
1.4
ug/g
278.6
284.3
0.28
347
2798
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
31
421
0.53
3.15
1.5
1.4
mmol/l
7.7
8.4
0.40
17
257
(3000060) B lymphocytes [#/volume] in Blood
26
373
0.50
3.14
1.3
2.0
e6/l
2141.8
200.5
0.48
11
212
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
180
986
1.32
3.13
1.3
1.4
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
52
610
0.61
3.08
1.3
1.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
86
416
1.49
3.07
1.7
2.0
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
1962
13103
1.09
3.02
5.7
6.7
%
96.0
95.8
0.73
1895
12600
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
56
641
0.63
3.00
11.1
15.2
nmol/l
1311.3
5429.7
0.84
47
612
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
467
3949
0.85
2.96
1.3
1.5
iu/ml
12.7
18.6
0.49
11
118
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
92
950
0.70
2.96
2.5
2.3
e6/l
495.4
523.9
0.18
74
804
(3017569) Oxygen content in Arterial blood
109
557
1.41
2.94
2.4
2.1
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
58
259
1.62
2.94
1.2
1.3
g/l
32.6
28.5
1.15
46
202
(3002621) Streptococcal DNAse B [Units/volume] in Serum
26
90
2.09
2.91
1.1
1.0
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
506
4242
0.86
2.88
2.0
2.2
mg/l
10.4
11.0
0.79
465
3909
(3009871) Measles virus Ab [Titer] in Serum
49
570
0.62
2.84
1.6
1.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
466
3924
0.85
2.82
1.5
1.4
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
1839
12291
1.09
2.80
6.1
7.0
g/l
118.0
118.6
0.78
1778
11838
(40768446) Kidney Pathology biopsy report
34
431
0.57
2.77
1.5
1.6
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
17
50
2.45
2.74
1.1
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
31
401
0.56
2.72
1.2
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
8
158
0.37
2.72
1.3
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
815
6587
0.89
2.72
1.9
2.1
u/l
41.6
40.1
1.37
714
5864
(3004775) Volume in Urine collected for unspecified duration
94
950
0.71
2.70
1.7
2.3
ml
638.1
634.2
0.03
56
671
(3000494) Fungus identified in Specimen by Culture
2581
17507
1.07
2.67
1.4
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
281
2459
0.82
2.66
1.5
1.6
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
85
424
1.45
2.65
1.2
1.9
u/ml
189482.0
27324.6
—
7
65
(3045142) Bone marrow Pathology biopsy report
239
1391
1.24
2.64
1.2
1.3
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
84
860
0.70
2.62
1.1
1.2
u/l
172.4
265.1
1.36
79
800
(3024932) HLA-DR beta [Type]
27
358
0.54
2.60
1.3
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
5044
34944
1.05
2.57
1.5
1.5
nmol/l
21.7
21.7
0.11
4137
29629
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
135
1278
0.76
2.54
1.0
1.1
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
11
199
0.40
2.53
1.2
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
419
2585
1.17
2.52
1.5
1.6
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
90
460
1.41
2.49
1.5
1.8
e6/l
2882.5
2376.2
0.08
52
291
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
16
246
0.47
2.44
2.4
1.9
umol/l
13.7
18.1
1.34
16
246
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
29
369
0.57
2.44
1.3
1.5
—
—
—
0
0
(3024471) HLA-A [Type]
29
369
0.57
2.44
1.1
1.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
265
2309
0.83
2.43
1.4
1.5
—
—
—
0
0
(44813793)
134
1260
0.77
2.42
1.1
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
74
367
1.46
2.41
1.6
1.8
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
108
573
1.36
2.41
2.1
2.0
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
81
409
1.43
2.41
1.5
1.7
e6/l
5440.9
14183.8
0.76
39
195
(4198724)
26
339
0.55
2.39
1.0
1.4
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
33
403
0.59
2.39
1.0
1.0
u/ml
0.3
0.7
0.61
17
197
(3013707) Erythrocyte sedimentation rate by Westergren method
15927
116515
0.96
2.39
3.9
4.3
mm/h
14.2
12.9
22.40
14462
108167
(3041918) Cholesterol [Moles/volume] in Pleural fluid
45
200
1.62
2.38
1.2
1.2
mmol/l
2.1
1.9
0.52
34
107
(3001964) Herpes simplex virus Ag [Presence] in Specimen
82
416
1.42
2.38
1.1
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
237
2079
0.82
2.35
1.2
1.3
—
—
—
0
0
(3016750) Collection duration of Urine
70
723
0.70
2.34
1.7
2.1
min
498.4
500.0
0.05
45
557
(3006653) Thiamine [Moles/volume] in Blood
68
706
0.69
2.34
1.2
1.4
nmol/l
133.8
133.4
0.03
68
706
(3042010) Triglyceride [Moles/volume] in Pleural fluid
38
163
1.68
2.31
1.3
1.3
mmol/l
2.0
2.0
0.01
26
99
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
257
1532
1.21
2.31
5.2
6.1
mg/l
12.4
12.2
0.19
231
1392
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
53
575
0.66
2.30
1.4
1.6
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
168
956
1.27
2.30
1.3
1.4
umol/l
11.6
11.5
0.03
163
906
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
32
389
0.59
2.29
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
32
389
0.59
2.29
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
32
389
0.59
2.29
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
32
389
0.59
2.29
1.0
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
3054
23164
0.94
2.27
1.2
1.2
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
61
295
1.49
2.27
1.2
1.1
pmol/l
2.2
8.5
—
7
39
(3033799) Differential panel - Peritoneal fluid
76
384
1.43
2.27
1.5
1.7
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
260
1559
1.21
2.21
1.2
1.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
110
595
1.34
2.20
2.3
2.3
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
433
3588
0.87
2.20
1.3
1.3
mg/l
546.9
537.2
0.11
412
3422
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
379
3171
0.86
2.20
1.2
1.2
mmol/l
3.6
3.7
1.45
357
2976
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
95
922
0.74
2.19
2.4
2.5
e6/l
581.4
849.3
1.28
44
414
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
739
4792
1.12
2.18
3.1
3.6
mmol/l
25.3
25.2
0.67
670
4378
(3016650) Hepatitis A virus Ab [Presence] in Serum
256
2210
0.83
2.17
1.1
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
77
771
0.72
2.17
1.4
1.4
nmol/l
1.4
1.2
0.21
59
604
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
1494
11584
0.93
2.16
2.1
2.3
ug/l
4.4
5.8
4.39
1219
9804
(3013293) Extractable nuclear Ab [Presence] in Serum
27
337
0.58
2.16
1.3
1.5
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
86
449
1.38
2.15
1.1
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
371
3100
0.86
2.13
1.8
1.8
u/l
2083.6
3502.7
0.68
123
1199
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
97
933
0.75
2.11
1.5
1.4
u/l
5.4
5.4
0.00
74
782
(4024509)
278
1687
1.19
2.10
1.7
1.7
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
193
1130
1.23
2.10
2.1
2.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
557
4523
0.89
2.09
1.4
1.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
1891
14516
0.93
2.08
2.2
2.1
nmol/l
386.4
375.1
1.48
1728
13269
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
193
1702
0.82
2.06
1.5
1.4
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
65
326
1.44
2.05
1.1
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
163
1461
0.80
2.04
1.1
1.1
—
93.3
—
0
19
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
512
4171
0.88
2.04
1.1
1.2
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
884
5810
1.10
2.04
3.0
3.9
mmol/l
24.6
24.5
0.86
781
5208
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
29
349
0.60
2.03
1.2
1.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
369
2303
1.16
2.00
2.2
2.6
umol/l
36.6
32.9
1.70
298
1954
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
223
1931
0.83
1.99
1.1
1.1
g/l
1.6
1.5
1.64
200
1732
(3016228) CD19 cells/100 cells in Blood
98
532
1.33
1.95
1.8
2.0
%
9.9
8.4
0.45
93
522
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
112
620
1.30
1.95
1.1
1.1
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
164
1460
0.81
1.94
1.1
1.1
—
45.8
—
0
16
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
6
114
0.38
1.93
1.0
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
827
5437
1.10
1.92
3.0
3.4
—
—
—
0
0
(3000012) Reticulocyte production index
130
736
1.28
1.91
1.5
1.5
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
40
184
1.57
1.91
1.0
1.1
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
32
139
1.66
1.90
1.9
2.1
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
73
719
0.73
1.90
1.2
1.6
nmol/l
1.4
1.3
0.41
51
576
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
225
1936
0.84
1.89
1.6
1.6
%
56.2
53.4
0.49
147
1167
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
1158
7735
1.08
1.88
2.9
3.3
kpa
5.2
5.2
0.45
1060
7104
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
543
3494
1.12
1.88
1.4
1.3
—
—
—
0
0
(3012544) pH of Venous blood
1803
12248
1.07
1.86
2.8
3.5
ph
7.4
7.4
—
8
53
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
10
163
0.44
1.85
2.0
1.7
mg/l
1.6
1.5
—
10
138
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
27
322
0.60
1.85
1.2
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
75
731
0.74
1.84
1.1
1.2
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
42
452
0.67
1.82
1.9
1.4
%
48.8
50.5
0.10
30
385
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
74
721
0.74
1.81
1.1
1.1
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
102
950
0.77
1.81
1.7
1.9
nmol/l
16.1
16.7
0.29
94
893
(3035637) Corticotropin [Mass/volume] in Plasma
286
1768
1.17
1.79
1.4
1.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
1102
7366
1.08
1.78
2.9
3.3
mmol/l
2.2
2.1
0.39
873
5607
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
198
1187
1.21
1.76
5.9
6.1
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
82
783
0.75
1.76
1.4
1.5
%
3.0
4.2
0.48
22
153
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
68
667
0.73
1.75
1.4
1.4
umol/l
2.6
3.4
1.59
63
605
(3030313) Adrenal Ab [Titer] in Serum
8
129
0.45
1.73
1.0
1.0
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
57
290
1.42
1.72
1.2
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
271
2273
0.86
1.71
1.3
1.2
—
—
—
0
0
(3009343) pH of Capillary blood
1139
7644
1.08
1.68
2.9
3.3
ph
7.4
7.4
2.50
172
1014
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
35
383
0.66
1.67
1.1
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
7909
55776
1.03
1.65
3.4
3.4
ng/l
31.0
54.7
1.50
5552
35395
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
30
134
1.62
1.64
1.0
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
264
2211
0.86
1.64
1.1
1.1
u/ml
3.1
3.2
0.02
108
1017
(3000330) Specific gravity of Urine by Test strip
1007
7829
0.92
1.64
3.8
3.6
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
160
1397
0.83
1.62
1.1
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
160
1396
0.83
1.61
1.1
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
160
1396
0.83
1.61
1.1
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
159
1388
0.83
1.61
1.1
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
159
1387
0.83
1.60
1.1
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
159
1385
0.83
1.58
1.1
1.2
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
11
162
0.49
1.58
1.2
2.3
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
43
445
0.70
1.56
1.3
1.5
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
31
0.00
1.56
0.0
1.3
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
6
104
0.42
1.55
1.0
1.0
u/ml
0.0
0.2
—
6
77
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
12
40
2.16
1.55
1.0
1.1
ng/l
3300.3
5803.9
—
7
21
(3014271) Vancomycin [Susceptibility]
128
746
1.24
1.54
2.8
3.0
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
89
823
0.78
1.54
2.0
2.1
ug/l
2.5
2.8
0.35
75
702
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
39
409
0.69
1.53
1.1
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
1187
9144
0.93
1.52
1.3
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
472
3785
0.90
1.52
2.3
2.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
93
524
1.28
1.49
1.8
2.0
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
2126
14626
1.05
1.47
2.1
2.4
%
1.9
1.8
1.04
1866
12809
(3019977) pH of Arterial blood
116
673
1.24
1.47
2.7
2.6
ph
7.4
7.4
0.52
54
228
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
38
185
1.48
1.47
1.0
1.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
32
150
1.54
1.47
1.8
2.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
104
596
1.26
1.46
8.0
10.6
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
160
1379
0.84
1.45
1.2
1.2
u/ml
14.6
49.6
5.71
18
117
(44806071)
16
203
0.57
1.45
1.1
1.1
—
—
—
0
0
(44806420)
39
404
0.70
1.45
2.1
2.4
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
93
847
0.79
1.44
2.0
2.0
ug/l
3.5
4.2
0.48
81
754
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
160
1377
0.84
1.43
1.2
1.2
u/ml
84.1
66.4
—
10
83
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
57
553
0.74
1.42
1.1
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
1377
10525
0.94
1.41
3.5
3.2
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
263
1653
1.15
1.40
3.7
3.1
nmol/l
4.9
8.3
0.50
256
1588
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
584
4609
0.91
1.40
1.8
1.9
iu/l
20.3
12.7
0.19
209
1711
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
10
144
0.50
1.38
1.3
1.1
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
28
0.00
1.38
0.0
1.0
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
159
961
1.19
1.37
1.6
1.7
mmol/24h
6.1
5.2
0.41
16
77
(3009214) Lutropin [Units/volume] in Serum or Plasma
326
2082
1.13
1.37
1.2
1.2
u/l
22.8
20.7
1.32
278
1685
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
29
0.00
1.37
0.0
1.3
—
—
—
0
0
(3009883) Potato IgE Ab [Units/volume] in Serum
0
29
0.00
1.37
0.0
1.0
—
0.2
—
0
18
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
280
2298
0.88
1.37
1.1
1.1
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
230
1435
1.16
1.36
4.6
7.2
mmol/l
7.0
7.5
1.05
193
1169
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
35
171
1.48
1.35
1.4
1.6
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
86
783
0.79
1.35
1.1
1.2
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
24
269
0.64
1.34
1.0
1.0
—
0.9
—
0
6
(3034092) Cytoplasmic Ig cells/100 cells in Blood
14
179
0.56
1.32
12.9
9.7
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
16
197
0.59
1.32
1.2
1.1
umol/24h
1.8
1.6
0.69
16
197
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
68
375
1.31
1.31
1.2
1.1
—
—
—
0
0
(4094501)
519
4104
0.91
1.31
1.1
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
1723
11833
1.05
1.30
2.8
3.5
mmol/l
2.2
2.1
0.22
1426
9856
(3043681) Transitional cells [#/area] in Urine by Computer assisted method
20
86
1.68
1.30
1.0
1.1
u/field
1.0
1.3
1.27
13
60
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
78
714
0.79
1.29
12.2
12.1
mmol/l
0.7
0.6
0.72
69
649
(3032743) Legionella sp IgG Ab [Presence] in Serum
19
81
1.69
1.28
1.0
1.1
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
19
81
1.69
1.28
1.0
1.1
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
101
589
1.24
1.26
2.6
2.4
mmol/l
9.5
9.1
0.68
82
427
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
4027
28198
1.04
1.26
3.3
3.6
ng/l
124.9
278.2
8.93
3126
20674
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
19
221
0.62
1.26
1.1
1.1
u/ml
1.3
0.3
0.35
13
135
(3013005) Retinol [Moles/volume] in Serum or Plasma
68
630
0.78
1.25
1.3
1.6
umol/l
2.1
2.0
0.32
61
582
(3011985) Renin [Units/volume] in Plasma
276
2250
0.88
1.24
1.4
1.5
mu/l
51.7
50.7
0.04
241
2010
(3046861) Legionella sp Ag [Presence] in Urine
15
60
1.80
1.24
1.2
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
1006
6814
1.07
1.23
7.2
8.3
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
96
849
0.81
1.19
1.2
1.3
mmol/l
5.9
5.8
0.28
89
795
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
57
536
0.77
1.19
2.5
2.9
—
—
—
0
0
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
25
0.00
1.19
0.0
1.4
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
168
1412
0.86
1.18
1.6
1.4
e6/l
177612.5
99105.5
0.67
110
966
(3020191) Ethanol [Moles/volume] in Serum or Plasma
91
808
0.81
1.18
1.2
1.5
promille
1.2
1.2
0.06
72
596
(3000475) Leukocytes [#/volume] in Synovial fluid
478
3769
0.91
1.17
1.7
1.7
e6/l
15682.1
10465.6
1.34
344
2737
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
110
654
1.21
1.17
1.1
1.0
%
101.2
96.5
1.01
89
500
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
8
114
0.51
1.16
1.4
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
375
2989
0.90
1.15
1.3
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
85
758
0.81
1.15
1.7
1.7
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
98
861
0.82
1.15
1.3
1.4
umol/l
39.0
25.5
2.92
92
810
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
155
1307
0.85
1.15
1.2
1.2
u/ml
2.0
9.4
—
10
107
(3015147) Influenza virus A IgG Ab [Units/volume] in Serum
5
14
2.58
1.14
1.0
1.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
974
7464
0.94
1.14
1.9
1.9
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
30
148
1.46
1.14
1.0
1.1
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
75
430
1.26
1.12
3.4
3.1
ng/l
60.8
118.0
1.28
22
129
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
135
1148
0.85
1.12
1.1
1.1
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
75
675
0.80
1.11
2.0
2.8
%
42.2
42.2
0.01
22
241
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
2728
19017
1.04
1.11
2.1
2.5
%
21.2
21.7
0.96
2371
16067
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
234
1909
0.88
1.10
1.1
1.1
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
23
108
1.54
1.10
2.6
2.4
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
45
431
0.75
1.09
3.6
2.8
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
27
132
1.48
1.08
1.2
1.3
u/l
34.8
337.7
0.66
20
89
(4133840)
32
322
0.72
1.07
1.2
1.2
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
47
255
1.33
1.06
1.2
1.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
487
3232
1.09
1.06
2.1
2.5
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
1719
11882
1.05
1.05
2.8
3.5
kpa
5.8
5.8
0.71
1661
11555
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
82
725
0.82
1.05
1.1
1.1
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
2561
17856
1.04
1.04
3.7
4.8
mmol/l
1.0
1.0
0.67
2337
16405
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
157
977
1.16
1.03
1.8
1.8
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
7
98
0.52
1.00
1.1
1.2
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
11
137
0.58
0.99
2.2
1.8
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
314
2497
0.91
0.97
1.3
1.2
nmol/l
0.2
0.2
1.17
20
151
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
16
180
0.64
0.97
1.0
1.0
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
2481
17318
1.04
0.96
2.4
2.5
umol/l
8.1
7.2
1.28
2101
14708
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
26
265
0.71
0.96
1.0
1.0
ug/l
87.7
79.4
0.58
18
208
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
56
317
1.28
0.96
1.1
1.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
26
130
1.44
0.95
1.1
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
48
445
0.78
0.95
1.0
1.0
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
126
1059
0.86
0.95
1.7
2.0
g/24h
0.3
0.9
—
6
56
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
6
19
2.28
0.94
1.0
1.6
umol/l
3843.3
2830.6
—
6
19
(3028717) Thiamine [Mass/volume] in Blood
15
170
0.64
0.94
1.1
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
82
715
0.83
0.94
1.4
1.3
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
118
996
0.85
0.94
1.0
1.0
ng/l
41.5
44.8
0.37
89
701
(3025018) Bordetella pertussis Ab [Titer] in Serum
119
1003
0.86
0.93
1.3
1.3
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
93
560
1.20
0.92
1.7
1.5
ug/l
0.4
0.4
0.10
67
355
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
13315
96974
0.98
0.91
3.0
3.0
u/l
51.9
43.0
13.87
12199
90093
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
152
1255
0.87
0.91
1.1
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
561
3775
1.07
0.90
2.4
2.3
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
60
346
1.25
0.90
1.1
1.1
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
165
1044
1.14
0.90
1.3
1.2
titre
588.0
449.1
—
10
68
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
38
206
1.33
0.90
1.1
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
363
2853
0.92
0.89
1.5
1.5
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
465
3111
1.08
0.88
2.0
2.1
g/l
127.0
127.1
0.03
311
2223
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
38
207
1.32
0.87
1.1
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
38
207
1.32
0.87
1.1
1.1
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
161
1020
1.14
0.87
1.3
1.2
titre
34.5
57.7
1.48
20
81
(1616796) Gas panel - Central venous blood
419
2794
1.08
0.86
3.2
3.3
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
36
195
1.33
0.86
1.3
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
1565
10858
1.04
0.85
3.2
2.8
e9/l
3.8
4.0
2.04
1216
8257
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
312
2055
1.10
0.85
1.1
1.1
%
125.5
125.1
0.07
283
1830
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
1169
8823
0.95
0.85
2.4
2.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
343
2695
0.92
0.85
1.3
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
99
606
1.18
0.84
1.2
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
99
606
1.18
0.84
1.2
1.5
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
11
130
0.61
0.84
1.1
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
61
356
1.24
0.84
1.0
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
337
2230
1.09
0.84
2.5
2.7
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
118
983
0.87
0.82
1.0
1.0
ng/l
613.5
336.6
0.46
89
704
(3008295) Osmolality of Serum or Plasma
227
1475
1.11
0.82
1.3
1.4
mosm/kgh2o
274.6
275.9
0.35
169
1122
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
311
2448
0.92
0.82
1.1
1.1
au/ml
7.0
12.2
1.15
12
111
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
119
990
0.87
0.82
1.0
1.0
ng/l
735.2
738.6
0.03
87
682
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
136
1120
0.88
0.81
1.1
1.1
iu/ml
7.2
9.3
0.57
37
257
(3027859) Formaldehyde IgE Ab [Units/volume] in Serum
0
18
0.00
0.81
0.0
1.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
6
23
1.88
0.81
1.0
1.1
%
2.0
2.0
—
6
23
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
21
105
1.44
0.80
2.5
2.8
mmol/l
0.7
0.8
0.25
16
69
(3050794) Legionella sp Ab [Presence] in Serum
21
105
1.44
0.80
1.0
1.1
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
7
89
0.57
0.79
3.7
2.0
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
36
336
0.77
0.79
1.3
1.3
mg/l
0.8
15.2
0.49
27
243
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
283
2232
0.91
0.79
1.1
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
30
287
0.75
0.78
1.4
1.2
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
17
179
0.68
0.78
1.1
1.1
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
42
384
0.79
0.78
1.8
2.4
nmol/l
177.5
161.1
0.47
34
340
(3033923) Metanephrine [Moles/time] in 24 hour Urine
46
416
0.80
0.78
1.2
1.1
umol/24h
0.5
0.7
1.50
16
197
(40760888) Immunoglobulin light chains.free panel - Serum
426
3302
0.93
0.78
3.2
3.5
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
11
127
0.62
0.78
1.1
1.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
1420
9858
1.04
0.77
2.5
3.0
kpa
4.5
4.5
0.14
1364
9570
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
61
361
1.22
0.76
1.0
1.1
—
—
—
0
0
(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma
9
39
1.66
0.74
2.3
2.0
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
136
1111
0.88
0.74
1.1
1.0
mg/l
316.8
572.2
0.46
116
983
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
6
79
0.55
0.74
1.0
1.0
—
—
—
0
0
(3026726) Creatinine [Moles/volume] in Specimen
6
80
0.54
0.73
1.2
2.6
umol/l
348.7
460.2
—
6
80
(40765089) Chromosome analysis panel - Blood by G-banded
11
125
0.63
0.73
1.0
1.0
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
319
2492
0.92
0.73
1.3
1.2
nmol/l
3.2
1.3
0.34
310
2394
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
15
159
0.68
0.73
4.5
5.3
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
128
1048
0.88
0.72
1.2
1.3
mmol/l
11.4
11.6
0.11
38
278
(3036071) Salmonella sp Ab [Titer] in Serum
49
435
0.81
0.72
1.0
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
99
824
0.87
0.71
1.7
1.9
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
17
175
0.70
0.71
1.7
2.7
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
33
306
0.78
0.71
1.2
1.1
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
10
115
0.63
0.71
1.0
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
624
4756
0.95
0.70
1.2
1.2
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
111
915
0.87
0.70
1.1
1.1
nmol/l
2.3
6.2
0.96
14
178
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
10
43
1.68
0.70
1.0
1.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
1585
11820
0.97
0.69
3.0
3.3
pmol/l
4.4
4.4
0.20
1405
10424
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
7
86
0.59
0.69
4.1
6.5
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
172
1115
1.11
0.69
3.6
3.0
nmol/l
137.6
129.2
0.12
167
1097
(3010503) CD19 cells [#/volume] in Blood
129
822
1.13
0.69
2.4
2.5
e9/l
0.3
0.3
0.05
124
801
(3045424) Erythrocytes [Presence] in Urine
404
2723
1.07
0.68
1.4
1.6
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
237
1563
1.09
0.68
1.3
1.5
—
—
—
0
0
(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine
5
68
0.53
0.68
1.2
1.0
pmol/l
182.0
203.1
—
5
32
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
14
148
0.68
0.68
1.0
1.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
32
178
1.30
0.68
1.0
1.9
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
541
4134
0.94
0.68
3.3
4.1
mmol/l
3.8
3.8
0.05
510
3912
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
31
287
0.78
0.67
1.8
2.2
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
264
2068
0.92
0.66
1.3
1.3
pmol/l
374.7
290.2
0.36
210
1639
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
293
2283
0.92
0.65
1.3
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
633
4807
0.95
0.65
1.2
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
157
1018
1.11
0.64
1.8
1.7
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
273
2131
0.92
0.64
1.2
1.2
u/ml
3.8
3.8
0.03
107
882
(40765096) Chromosome analysis panel by Banding
56
336
1.20
0.64
1.2
1.1
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
205
1348
1.10
0.64
1.1
1.2
nmol/l
340.3
372.3
1.47
178
1145
(3026692) Albumin [Mass/volume] in Peritoneal fluid
49
290
1.22
0.64
1.1
1.3
g/l
16.6
13.4
1.75
40
223
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
81
677
0.86
0.64
1.2
1.3
%
55.9
56.3
0.02
14
80
(4015189)
44
388
0.82
0.63
2.0
2.6
—
—
—
0
0
(4211845)
129
828
1.12
0.63
4.3
3.2
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
68
575
0.85
0.62
1.7
1.8
umol/l
259.5
121.1
1.09
41
315
(4146454)
230
1523
1.09
0.62
2.6
2.7
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
187
1482
0.91
0.62
1.5
1.5
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
116
943
0.89
0.62
1.0
1.0
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
0
15
0.00
0.62
0.0
1.2
—
—
—
0
0
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
0
15
0.00
0.62
0.0
1.2
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
29
162
1.29
0.61
1.0
1.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
634
4803
0.95
0.60
1.2
1.2
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
428
2907
1.06
0.60
1.3
1.4
mmol/l
60.6
60.8
0.03
330
2304
(3044927) Protein electrophoresis panel - Urine
178
1409
0.91
0.59
1.2
1.2
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
62
525
0.85
0.59
2.2
2.3
umol/l
45.6
55.4
1.92
45
404
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
136
1091
0.90
0.59
1.5
1.3
nmol/l
1.6
1.5
0.41
123
984
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
8
38
1.52
0.58
1.1
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
28
257
0.79
0.58
5.3
5.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
2393
17672
0.97
0.58
1.3
1.3
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
35
202
1.25
0.58
1.0
1.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
202
1336
1.09
0.58
2.0
2.2
u/field
3.0
2.8
0.11
86
542
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
709
5348
0.96
0.58
1.7
1.7
mg/l
2.5
3.4
3.72
544
3845
(3008536) Aspergillus sp Ab [Presence] in Serum
42
249
1.22
0.56
2.5
1.8
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
151
987
1.10
0.56
1.6
1.8
mmol/l
6.9
6.9
0.04
107
668
(3019420) Tryptase [Mass/volume] in Serum or Plasma
106
859
0.89
0.56
1.4
1.6
ug/l
7.6
8.7
0.46
98
776
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
17
166
0.74
0.55
11.6
11.9
mmol/l
4.2
4.7
0.64
17
166
(3047189) Immunofixation for 24 hour Urine
68
567
0.86
0.55
2.0
1.9
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
799
5535
1.04
0.54
4.2
4.5
%
1.5
1.6
4.53
761
5188
(3037756) Immunofixation for Serum or Plasma
382
2923
0.94
0.54
1.7
1.8
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
386
2626
1.06
0.54
2.4
2.7
kpa
8.2
8.2
0.11
354
2442
(3008037) Lactate [Moles/volume] in Venous blood
444
3034
1.06
0.53
3.1
3.0
mmol/l
1.5
1.5
0.10
439
2977
(3044941) Cell count panel - Synovial fluid
314
2415
0.94
0.53
1.5
1.4
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
58
358
1.17
0.52
1.1
1.1
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
566
4277
0.95
0.52
2.9
3.4
ratio
3.1
4.2
0.23
32
340
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
189
1255
1.09
0.52
3.6
3.8
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
254
1707
1.07
0.51
2.4
2.3
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
21
196
0.77
0.51
1.1
1.0
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
2911
20606
1.02
0.50
2.0
2.4
g/l
2.4
2.4
0.17
2657
18881
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
36
314
0.83
0.50
1.2
1.3
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
14
138
0.73
0.49
2.3
2.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
169
1326
0.92
0.49
1.8
2.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
786
5459
1.04
0.49
4.2
4.5
%
0.9
0.9
0.55
746
5113
(3024928) Oxygen saturation in Venous blood
377
2573
1.06
0.49
2.0
3.2
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
364
2482
1.06
0.49
3.0
5.3
iu/ml
860.3
796.5
0.05
28
386
(3019174) dRVVT (LA screen)
13
129
0.73
0.48
1.1
1.2
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
20
185
0.78
0.47
1.3
1.5
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
5
59
0.61
0.46
1.0
1.1
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
5
60
0.60
0.46
3.0
2.6
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
132
868
1.10
0.46
1.9
1.9
u/field
1.7
2.2
0.61
92
606
(3027570) Oxalate [Moles/time] in 24 hour Urine
5
61
0.59
0.46
1.0
1.6
umol/24h
355.6
312.2
—
5
61
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
11
55
1.44
0.45
1.0
1.0
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
90
581
1.12
0.45
1.1
1.1
ng/l
362.8
675.9
0.40
24
125
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
99
791
0.90
0.44
1.5
1.8
%
110.4
101.2
1.75
88
726
(36660697) Celiac disease serology panel - Serum
1749
12904
0.98
0.44
1.2
1.2
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
12
118
0.73
0.43
1.2
1.2
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
13
126
0.74
0.43
7.9
6.6
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
6655
48486
0.99
0.42
2.4
2.4
u/l
58.4
57.9
0.20
6051
44449
(3000876) Codfish IgE Ab [Units/volume] in Serum
0
11
0.00
0.42
0.0
1.0
—
—
—
0
0
(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
0
11
0.00
0.42
0.0
1.2
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
11
0.00
0.42
0.0
1.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
71
576
0.89
0.42
1.1
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
96
765
0.90
0.41
1.6
1.8
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
8
42
1.37
0.41
1.1
1.1
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
27
159
1.23
0.41
1.0
1.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
169
1312
0.93
0.41
2.2
2.3
e9/l
1.1
1.2
0.18
110
780
(3001218) Citrate [Mass/time] in 24 hour Urine
0
13
0.00
0.41
0.0
1.5
—
—
—
0
0
(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
13
0.00
0.41
0.0
1.0
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
5
24
1.50
0.41
1.0
2.5
mu/l
2.9
1.4
—
5
24
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
65
529
0.89
0.41
1.2
1.2
%
109.8
114.1
0.60
55
466
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
15
141
0.77
0.41
4.3
6.8
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
16
88
1.31
0.40
1.0
1.1
s
34.9
36.3
0.62
16
74
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
16
88
1.31
0.40
1.1
1.1
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
14
0.00
0.40
0.0
1.0
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
0
14
0.00
0.40
0.0
2.3
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
107
704
1.10
0.39
3.9
1.7
%
142.8
138.7
0.21
101
658
(3004347) Hepatitis D virus Ab [Presence] in Serum
5
25
1.44
0.39
1.0
1.0
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
96
761
0.91
0.39
1.4
1.6
nmol/l
3.0
3.6
0.29
85
620
(40760892) CBC W Ordered Manual Differential panel - Blood
4532
33080
0.99
0.38
3.8
4.5
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
22
195
0.81
0.38
3.4
5.2
ug/min
29.1
38.3
0.55
17
145
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
9
49
1.33
0.38
1.0
1.6
—
—
—
0
0
(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum
8
84
0.69
0.37
1.0
1.0
u/ml
0.0
0.2
—
8
74
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
115
762
1.09
0.37
1.5
1.7
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
276
1888
1.06
0.37
1.8
2.4
u/ml
4366.4
1139.4
0.36
12
90
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
19
109
1.26
0.37
1.1
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
1539
10870
1.02
0.37
2.2
2.5
e9/l
70.0
70.9
0.43
1142
8123
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
32
195
1.18
0.36
1.2
1.2
ng/l
104.1
73.0
0.32
19
125
(3034860) Kappa light chains.free [Mass/volume] in Serum
591
4414
0.97
0.36
3.0
3.4
mg/l
44.7
76.8
0.96
462
3607
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
5
56
0.64
0.36
1.0
1.2
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
5
56
0.64
0.36
1.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
5
56
0.64
0.36
1.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
5
56
0.64
0.36
1.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
5
56
0.64
0.36
1.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
5
58
0.62
0.36
1.0
1.0
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
24
209
0.83
0.36
1.5
1.4
%
50.8
49.7
—
9
116
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
6
30
1.44
0.36
1.0
1.0
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
135
1049
0.93
0.36
1.9
2.0
%
36.5
42.9
1.26
20
148
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
72
575
0.90
0.35
1.2
1.2
g/l
0.3
0.3
0.07
60
460
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
15
84
1.29
0.35
6.2
4.9
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
24
208
0.83
0.35
2.9
2.9
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
28
239
0.84
0.34
1.7
1.5
—
—
—
0
0
(3020891) Body temperature
734
5455
0.97
0.34
3.6
4.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
117
780
1.08
0.34
1.1
1.1
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
31
262
0.85
0.34
2.1
2.3
ug/l
4.3
3.7
0.17
15
105
(3038071) Oxygen [Partial pressure] in Mixed venous blood
22
192
0.83
0.34
12.3
8.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
751
5577
0.97
0.34
1.9
2.3
g/l
7.7
7.5
1.51
562
4091
(3043410) Blood group antigens tested for on Red Blood Cells
54
346
1.13
0.34
1.5
1.7
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
78
511
1.10
0.33
1.2
1.1
%
111.3
115.7
0.56
70
458
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
150
1156
0.94
0.33
1.6
1.9
mg/l
2.9
3.7
3.72
145
1100
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
104
812
0.92
0.32
1.1
1.1
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
56
450
0.90
0.31
1.2
1.3
%
24.5
23.0
0.05
11
85
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
751
5567
0.97
0.31
1.9
2.3
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
947
6669
1.03
0.31
1.1
1.1
u/ml
1.1
2.6
0.77
17
107
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
158
1071
1.06
0.31
1.2
1.3
mmol/l
2.2
2.2
0.18
144
988
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
750
5558
0.97
0.31
1.9
2.3
g/l
3.8
3.7
0.48
529
3895
(3006462) Nitrate [Presence] in Urine
114
764
1.08
0.31
4.4
3.3
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
19
112
1.22
0.31
1.1
1.1
—
—
—
0
0
(3025315) Body weight
11
103
0.77
0.30
4.8
4.7
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
591
4395
0.97
0.30
3.0
3.4
mg/l
38.3
41.5
0.21
463
3584
(3001729) Color of Synovial fluid
20
119
1.21
0.30
2.3
1.7
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
7
40
1.26
0.30
2.7
1.1
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
120
926
0.93
0.29
1.4
1.5
umol/l
57.3
63.4
—
8
66
(3019060) Gas panel - Arterial blood
1178
8669
0.98
0.28
3.9
4.4
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
99
663
1.08
0.28
1.5
1.4
pmol/l
15.6
15.0
0.61
76
555
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
55
358
1.11
0.28
1.1
1.1
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
27
226
0.86
0.28
1.2
1.1
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
43
348
0.89
0.28
1.3
1.3
nmol/l
90.0
126.8
1.84
30
234
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
90
701
0.93
0.28
1.1
1.1
u/ml
55.8
11.7
—
6
59
(40758047) Lysozyme [Mass/volume] in Pleural fluid
15
87
1.24
0.28
1.1
1.1
mg/l
9.9
10.6
0.08
15
77
(3002619) Bacteria identified in Specimen by Culture
37
302
0.88
0.28
1.2
1.3
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
51
331
1.11
0.27
4.4
5.7
mmol/l
24.8
25.6
0.84
42
304
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
119
916
0.94
0.27
1.2
1.1
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
8
47
1.23
0.27
1.5
1.4
nmol/l
438.5
432.8
—
8
47
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
47
304
1.12
0.27
1.1
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
114
770
1.07
0.26
1.1
1.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
8858
63548
1.01
0.26
1.9
2.0
pmol/l
99.9
99.5
0.28
3971
30004
(3011325) HIV 1+2 Ab [Presence] in Serum
5
53
0.68
0.26
1.0
1.0
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
74
579
0.92
0.26
2.1
2.1
ug/min
22.7
52.9
0.84
13
100
(4306422)
306
2126
1.04
0.25
1.1
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
131
1002
0.94
0.25
1.1
1.1
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
411
2872
1.03
0.25
3.3
3.1
mmol/l
7.3
7.4
0.67
406
2822
(3018572) Chloride [Moles/volume] in Blood
396
2949
0.97
0.25
5.5
6.0
mmol/l
105.4
105.0
0.95
359
2646
(3039000) Anion gap in Blood
396
2948
0.97
0.24
5.5
6.0
mmol/l
10.6
11.0
2.53
359
2645
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
51
334
1.10
0.24
1.1
1.1
—
—
—
0
0
(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
12
69
1.25
0.24
1.3
1.5
u/l
0.3
0.0
—
7
22
(3020779) Urea [Moles/volume] in Serum or Plasma
1434
10506
0.98
0.24
5.2
6.5
mmol/l
8.8
9.3
1.68
1367
9961
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
133
1013
0.95
0.23
1.7
2.0
%
13.0
14.7
0.65
35
469
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
617
4346
1.02
0.23
1.9
2.2
g/l
37.9
37.8
0.17
500
3659
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
14
122
0.83
0.23
1.9
2.7
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
52
410
0.91
0.23
1.0
1.2
pmol/l
215.5
347.6
3.50
38
297
(3025130) Human papilloma virus identified in Specimen
406
2844
1.03
0.23
1.5
1.7
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
440
3086
1.03
0.23
1.4
1.7
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
5
29
1.24
0.22
1.0
1.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
439
3080
1.03
0.22
2.5
2.8
mmol/l
25.8
25.2
1.78
371
2724
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
19
160
0.86
0.22
1.1
1.1
—
—
—
0
0
(3042628) Porphyrins [Moles/volume] in Urine
0
8
0.00
0.22
0.0
1.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
8
0.00
0.22
0.0
1.0
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
8
0.00
0.22
0.0
1.1
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
67
448
1.08
0.22
1.4
1.2
g/l
39.3
38.6
0.17
36
230
(3003129) Base excess in Capillary blood by calculation
47
309
1.10
0.22
1.7
1.8
mmol/l
1.7
1.1
0.43
42
297
(3016038) Potassium [Moles/volume] in Urine
156
1074
1.05
0.21
1.1
1.2
mmol/l
35.1
32.7
0.66
140
890
(3035611) Eosinophils/100 leukocytes in Synovial fluid
16
97
1.19
0.21
2.6
1.9
%
0.2
0.4
—
10
76
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
63
490
0.93
0.21
1.2
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
93
631
1.06
0.21
1.1
1.2
—
—
—
0
0
(3026906) Gabapentin [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
71.7
—
0
5
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
11
64
1.24
0.20
1.0
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
30
193
1.12
0.20
1.3
1.2
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
9
83
0.78
0.20
1.0
1.0
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
75
506
1.07
0.20
1.1
1.1
%
90.0
93.2
0.37
36
213
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
74
499
1.07
0.20
1.1
1.1
%
93.5
95.7
0.18
36
215
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
16
98
1.18
0.19
1.8
1.6
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
25
203
0.89
0.19
1.1
1.4
nmol/l
866674.5
246160.8
0.47
18
156
(3027273) Bicarbonate [Moles/volume] in Venous blood
877
6433
0.98
0.19
2.8
3.1
mmol/l
25.8
25.6
1.10
859
6255
(3012403) Metanephrines [Moles/time] in 24 hour Urine
6
38
1.14
0.19
1.0
1.1
—
21.8
—
0
8
(3052592) Norovirus Ag [Presence] in Stool
46
305
1.09
0.19
1.4
1.3
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
18
112
1.16
0.18
1.2
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
3980
28511
1.01
0.18
1.7
1.8
nmol/l
1155.8
1201.7
2.20
2838
21450
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
26
167
1.12
0.18
1.2
1.3
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
38
300
0.91
0.18
1.2
1.1
%
75.2
77.7
—
5
56
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
11
65
1.22
0.18
1.0
1.3
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
177
1326
0.96
0.18
2.5
2.9
mg/l
54.1
33.6
0.31
118
887
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
216
1506
1.03
0.18
1.1
1.1
%
97.3
95.6
0.39
204
1407
(3030981) Hyaline casts [#/volume] in Urine by Automated count
933
6832
0.98
0.17
2.4
2.5
e6/l
0.3
0.3
0.39
908
6558
(3041806) Other cells [#/volume] in Blood by Manual count
14
118
0.86
0.17
1.4
1.5
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
11
95
0.84
0.17
1.0
1.1
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
52
403
0.93
0.17
1.3
2.0
ug/l
13.1
3.1
0.41
26
253
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
45
300
1.08
0.17
1.6
1.6
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
14
86
1.17
0.16
1.1
1.0
—
—
—
0
0
(4268621)
191
1425
0.97
0.16
2.3
2.2
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
815
5969
0.98
0.16
3.4
3.7
%
47.0
47.8
0.44
807
5916
(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field
11
66
1.20
0.16
1.7
1.3
u/field
1.0
1.2
—
5
48
(3016273) Islet cell 512 Ab [Units/volume] in Serum
8
52
1.11
0.16
1.0
1.0
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
8
52
1.11
0.16
3.3
1.5
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
19
155
0.88
0.16
1.1
1.1
—
—
—
0
0
(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum
6
56
0.77
0.16
1.0
1.0
—
0.1
—
0
13
(3041672) Baker's yeast Ab [Presence] in Serum
6
58
0.75
0.15
1.0
1.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
1368
9759
1.01
0.15
2.1
2.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
69
470
1.06
0.15
1.2
1.1
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
447
3160
1.02
0.15
2.5
2.9
mg/l
1.4
1.5
2.72
394
2891
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
9
57
1.14
0.15
12.1
7.4
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
642
4705
0.98
0.14
3.2
3.9
mmol/l
1.4
1.3
0.64
636
4624
(4212803)
16
131
0.88
0.14
1.0
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
49
377
0.94
0.14
1.2
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
46
310
1.07
0.14
1.0
1.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
784
5734
0.99
0.14
1.5
1.7
g/l
1.7
1.6
1.17
639
4884
(3019768) Coxiella burnetii Ab [Presence] in Serum
11
67
1.18
0.14
1.2
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
22
143
1.11
0.13
1.1
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
111
770
1.04
0.13
1.1
1.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
710
5194
0.99
0.13
1.9
2.3
g/l
9.8
10.0
0.48
570
4259
(1175426) CD3 cells/100 lymphocytes in Blood
138
1029
0.97
0.13
1.7
2.0
%
71.4
73.5
0.78
128
990
(3005011) Chlamydia sp Ab [Titer] in Serum
29
227
0.92
0.13
1.9
1.7
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
1661
11883
1.01
0.12
2.5
2.8
ng/l
179.1
178.8
0.01
1515
10836
(37021550) Renin [Units/volume] in Plasma --upright
50
340
1.06
0.12
1.1
1.3
mu/l
83.9
66.8
0.17
34
253
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
857
6110
1.01
0.12
2.1
2.8
%
0.7
0.7
0.13
820
5851
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
40
270
1.07
0.12
7.4
4.9
u/l
41.9
46.9
0.40
14
119
(3008152) Bicarbonate [Moles/volume] in Arterial blood
1146
8348
0.99
0.12
5.6
6.4
mmol/l
25.2
24.9
2.85
1071
7768
(3032868) Hemoglobin electrophoresis panel in Blood
13
82
1.14
0.11
1.5
1.6
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
17
136
0.90
0.11
1.2
1.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
29
194
1.08
0.11
1.4
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
661
4825
0.99
0.10
2.6
2.9
g/l
0.2
0.3
5.62
209
1619
(3037556) Urate [Mass/volume] in Serum or Plasma
54
371
1.05
0.10
1.8
1.2
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
11
69
1.15
0.10
1.1
1.4
mmol/l
24.1
23.5
—
5
41
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
39
298
0.94
0.10
1.2
1.1
%
88.4
94.9
—
7
62
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
721
5257
0.99
0.10
1.9
2.3
g/l
3.2
3.1
1.52
544
3988
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
28
216
0.94
0.09
2.4
2.6
u/field
0.5
0.8
1.34
28
216
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
78
583
0.97
0.09
2.4
2.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
2689
19307
1.01
0.09
6.9
6.7
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
33
224
1.06
0.09
4.8
6.4
%
72.0
68.3
0.32
25
169
(3023419) Bacteria identified in Sputum by Culture
225
1654
0.98
0.09
2.5
2.6
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
172
1214
1.02
0.09
1.4
1.5
u/ml
24.5
22.2
0.18
25
237
(3032057) Clostridioides difficile [Presence] in Stool
48
362
0.96
0.08
1.9
1.7
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
16
105
1.10
0.08
1.1
1.1
u/l
7.1
10.4
0.53
16
105
(3042111) Morphology [Interpretation] in Bone marrow Narrative
293
2082
1.02
0.08
1.6
1.5
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
117
823
1.03
0.08
1.3
1.3
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
7
48
1.05
0.08
1.0
1.1
nmol/l
361.6
304.9
—
7
48
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
43
296
1.05
0.08
1.7
2.4
mmol/l
6.2
6.9
1.44
24
178
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
76
566
0.97
0.08
1.1
1.1
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
8
53
1.09
0.07
1.1
1.0
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
24
162
1.07
0.07
3.2
3.0
umol/l
33.9
40.1
0.66
19
137
(3020356) Listeria sp identified in Specimen by Organism specific culture
7
58
0.87
0.07
1.0
1.1
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
7
59
0.86
0.07
1.0
1.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
170
1204
1.02
0.07
1.1
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
96
675
1.03
0.07
1.4
1.3
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
9
74
0.88
0.06
1.1
1.0
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
9
76
0.85
0.06
2.9
4.1
—
—
—
0
0
(3004451) EKG impression Narrative
90
665
0.98
0.06
1.2
1.3
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
129
913
1.02
0.06
1.1
1.1
ratio
1.0
1.1
2.44
75
300
(3048879) Bone marrow aspiration report
52
388
0.97
0.06
1.7
1.8
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
300
2189
0.99
0.06
1.2
1.2
u/ml
3.1
3.8
0.43
84
716
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
10
80
0.90
0.05
1.0
1.0
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
575
4178
0.99
0.05
4.7
5.2
mmol/l
1.2
1.3
0.27
516
3687
(3036603) Volume of Urine
142
1041
0.98
0.05
1.4
1.5
ml
2000.1
1862.4
0.41
32
231
(3035933) Granulocytes/100 leukocytes in Blood
46
343
0.97
0.05
2.4
1.7
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
11
72
1.10
0.05
1.0
1.1
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
71
500
1.02
0.05
1.1
3.5
mg/l
8238.1
773.2
0.94
52
343
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
301
2151
1.01
0.04
1.1
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
53
393
0.97
0.04
1.1
1.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
657
4713
1.01
0.04
2.1
2.4
g/l
0.6
0.8
0.55
542
3999
(3027974) Hepatitis B virus e Ag [Presence] in Serum
10
79
0.91
0.04
1.2
1.6
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
1099
7959
1.00
0.04
2.5
3.1
g/l
124.2
126.9
4.13
1071
7784
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
15
101
1.07
0.04
1.0
1.1
iu/ml
20.7
19.2
—
6
20
(21494434) Karyotype in Bone marrow
149
1089
0.99
0.04
1.1
1.1
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
14
94
1.07
0.04
1.7
2.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
524
3802
0.99
0.04
4.8
4.6
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
124
907
0.99
0.04
1.1
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
65
479
0.98
0.03
1.1
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
192
1371
1.01
0.03
1.4
1.6
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
11
73
1.09
0.03
1.1
1.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
38
266
1.03
0.03
1.1
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
134
955
1.01
0.03
1.6
2.0
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
618
4478
1.00
0.03
1.9
2.1
ug/l
336.4
462.4
1.00
553
4145
(3003740) Influenza virus B Ag [Presence] in Specimen
272
1949
1.01
0.03
1.0
1.1
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
10
78
0.92
0.02
1.0
1.0
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
3130
22548
1.00
0.02
2.1
2.4
umol/l
12.6
12.8
1.15
2879
20684
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
68
499
0.98
0.02
1.1
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
27
188
1.04
0.02
1.1
1.7
—
—
—
0
0
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
14
95
1.06
0.02
1.6
1.3
ml/s/173m2
0.9
1.1
—
8
58
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
21
158
0.96
0.02
1.2
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
5767
41633
1.00
0.02
1.6
1.7
mmol/l
1.3
1.4
0.61
4738
35037
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
16
121
0.95
0.02
1.4
1.3
ug/l
82.9
114.4
—
7
77
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
532
3826
1.00
0.02
2.0
2.3
g/l
0.0
0.0
0.18
467
3460
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
244
1751
1.01
0.02
5.0
4.6
u/ml
98.2
141.0
0.45
66
507
(3002523) Influenza virus A Ag [Presence] in Specimen
271
1947
1.00
0.01
1.0
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
124
901
0.99
0.01
1.1
1.1
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
80
583
0.99
0.01
1.2
1.5
umol/l
32.4
31.0
0.65
75
561
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
68
496
0.99
0.01
4.4
1.7
%
161.7
162.3
0.02
63
467
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
11
75
1.06
0.00
1.1
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
90
654
0.99
0.00
1.2
1.1
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
10
74
0.97
0.00
1.0
1.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
18
130
1.00
0.00
1.6
1.6
umol/l
55.8
47.4
0.32
18
130
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
21
151
1.00
0.00
1.1
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
36
256
1.01
0.00
1.0
1.3
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
30
218
0.99
0.00
10.2
8.5
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
10
75
0.96
0.00
1.2
1.6
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
24
172
1.01
0.00
1.1
1.3
mmol/l
6.3
5.8
—
10
83
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
14
99
1.02
0.00
1.1
1.2
—
—
—
0
0
(3012565) Volume of 24 hour Urine
100
718
1.00
0.00
1.8
2.0
ml
1855.3
1902.2
0.20
90
640
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
52
372
1.01
0.00
1.4
1.3
%
41.7
40.7
0.06
34
243
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
573
4133
1.00
0.00
2.0
2.3
g/l
0.0
0.0
0.71
506
3751
(3020650) Glucose [Presence] in Urine
50
359
1.00
0.00
1.3
1.6
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
435
3134
1.00
0.00
3.8
3.5
mg/l
24.5
23.6
0.19
242
1972
(3005570) Glucose [Moles/volume] in Urine
235
1694
1.00
0.00
2.1
2.1
—
2.3
—
0
5
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
41
299
0.99
0.00
1.1
1.3
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
14
105
0.96
0.00
1.0
1.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
81
586
1.00
0.00
4.6
4.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
48
343
1.01
0.00
1.1
1.1
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
17
125
0.98
0.00
1.1
1.1
nmol/l
14.5
12.9
—
6
31
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
29
208
1.01
0.00
1.7
2.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
54
389
1.00
0.00
2.3
2.8
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
54
389
1.00
0.00
2.3
2.8
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
524
3777
1.00
0.00
2.0
2.3
g/l
0.0
0.0
0.00
466
3449
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
5
41
0.88
0.00
36.4
13.6
—
—
—
0
0
(3022670) pH of Venous cord blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006407) Chromogranin A [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
63.0
—
0
5
(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum
8
63
0.92
0.00
1.0
1.4
—
14639.2
—
0
5
(3017830) Gliadin IgG Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
7
54
0.94
0.00
1.3
1.0
—
—
—
0
0
(3049233) Organic acids panel - Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
5
42
0.86
0.00
1.0
1.2
—
—
—
0
0
(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045759) Histamine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
7
50
1.01
0.00
1.4
1.2
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
1.0
—
0
6
(40762887) Creatinine [Moles/volume] in Blood
6
45
0.96
0.00
1.2
1.2
—
—
—
0
0
(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
5
0.00
0.00
0.0
6.2
—
—
—
0
0
(3027114) Cholesterol [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016072) Theophylline [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3040794) Aluminum [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_BREAST – Malignant neoplasm of breast
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).